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Summary 
Woad (Isatis tinctoria L., Brassicaceae) is an ancient indigo dye and anti-inflammatory 
medicinal plant, which has been used and cultivated in Europe since antiquity. The anti-
inflammatory potential of lipophilic leaf extracts was recently confirmed in a broad-based 
pharmacological profiling, in various animal models and in a clinical pilot study. 
Tryptanthrin, an indolin-2-one derivative, and γ-linoleic acid were identified as 
pharmacologically active compounds inhibiting cyclooxygenase-2 (COX-2), 
5-lipoxygenase (5-LOX), the expression of the inducible nitric oxide synthase (iNOS), 
human neutrophil elastase, and the release of histamine from mast cells. Indirubin 
inhibits inflammatory reactions in delayed-type hypersensitivity and is a potent inhibitor 
of cyclin-dependent kinase 5 (CDK5) and glycogen synthase kinase 3β (GSK3B). 
In view of a development of this lipophilic woad extract towards a new anti-inflammatory 
herbal medicine, analytical tools were developed to address various issues related to 
quality control. This study was conducted as part of the development process and had 
the purpose to characterise the pharmacologically active leaf extracts of I. tinctoria and 
the closely related species I. indigotica Fort. As a first step, a gradient LC-PDA-MS 
method for the quantitative determination of pharmacologically relevant constituents and 
the dye indigo was developed and validated. The assay enabled quality assessment in 
the development of phytomedicinal preparations based on woad extracts. 
A comprehensive phytochemical profiling of the pharmacologically active 
dichloromethane extract from I. tinctoria leaves was carried out. The polar constituents 
of I. tinctoria (MeOH extract) and the taxonomically closely related TCM plant 
I. indigotica were also profiled for comparative purposes. PDA, ELSD, APCI- and ESI-
MS, and ESI-TOF-MS detectors were used in parallel to ensure a wide coverage of 
secondary metabolites with highly diverging structural properties. Off-line microprobe 
NMR after peak purification by semi-preparative HPLC enabled the structure elucidation 
of some minor constituents. More than 75 compounds belonging to various structural 
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classes such as alkaloids, flavonoids, fatty acids, porphyrins, lignans, carotenoids, 
glucosinolates and cyclohexenones were unambiguously identified, and tentative 
structures were proposed for additional compounds. Numerous compounds were 
identified for the first time in the genus Isatis, and a new indole alkaloid was discovered.  
The content of indole glucosinolates in woad, and their possible role as precursors of 
the alkaloid tryptanthrin was investigated. At first, a robust HPLC-MS method for the 
quantitative determination of glucosinolates was developed and validated. Direct 
analysis of glucosinolates was rendered possible by the use of a volatile ion-pairing 
reagent. Extraction via pressurised liquid extraction was optimized, and purity 
assessment of reference compounds was carried out with quantitative 1H-NMR.  
Seasonal fluctuations of glucosinolates in the leaf material of five defined I. tinctoria and 
one I. indigotica accessions were assessed. Significant qualitative and quantitative 
differences in the glucosinolate patterns were observed when comparing the two 
species, while differences among the various I. tinctoria accessions were much smaller. 
Repeated harvesting during the growth season did not have a major effect on 
glucosinolate concentrations of newly grown leaves. 
We investigated the influence of the drying procedure on the glucosinolate content. In 
contrast to shock frozen samples, none of the glucosinolates could be detected in plant 
material that had been dried at ambient temperature or at 40 °C. However, none of the 
known breakdown products of indole glucosinolates could be detected.   
The glucosinolate patterns in seeds of the five I. tinctoria and two I. indigotica 
accessions were also investigated. The glucosinolate patterns of the seeds showed 
characteristic differences compared to leaves. Qualitative and quantitative differences in 
glucosinolate patterns between both Isatis species were found, enabling a differentiation 
of the two species at the level of seed material. 
 
12
Zusammenfassung 
Färberwaid (Isatis tinctoria L.) ist eine historische Indigofärberpflanze mit enzündungs-
hemmenden Eigenschaften und wird bereits seit der Antike in Europa kultiviert und 
angewendet. Die entzündungshemmende Wirkung der lipophilen Blattextrakte wurde 
kürzlich in einem breit angelegten, pharmakologischen Screeningprogramm sowie in 
zahlreichen Tierversuchen und einer klinischen Pilotstudie bestätigt.  
Tryptanthrin, ein Indolin-2-on-derivat und γ-Linolensäure wurden als pharmakologisch 
wirksame Verbindungen identifiziert und es konnte gezeigt werden, dass diese Stoffe in 
der Lage sind Targets wie Cyclooxygenase-2 (COX-2), 5-Lipoxygenase (5-LOX), die 
humane, neutrophile Elastase, die Expression der induzierbaren NO Synthase (iNOS) 
sowie die Freisetzung von Histamin aus Mastzellen zu hemmen. Indirubin stoppt die 
Entzündung bei Überempfindlichkeitsreaktionen vom Spättyp und ist ein wirksamer 
Inhibitor der cyclin-abhängigen Kinase 5 (CDK5) und der Glycogensynthase Kinase 3β 
(GSK3B). 
Für die Weiterentwicklung dieses entzündungshemmenden, lipophilen Waidextraktes zu 
einem Phytopharmakon wurden analytische Methoden für verschiedene Frage-
stellungen in der Qualitätskontrolle erarbeitet. Diese Arbeit ist als Teil dieses 
Entwicklungsprozesses einzuordnen und hat den Zweck die pharmakologisch aktiven 
Blattextrakte von I. tinctoria und der nahe verwandten Art I. indigotica Fort. zu 
charakterisieren. In einem ersten Schritt wurde eine LC-PDA-MS Methode entwickelt 
und validiert, die eine quantitative Bestimmung der pharmakologisch relevanten Inhalts-
stoffe sowie des Indigofarbstoffs ermöglicht. Diese Methode kann zur Qualitätsprüfung 
bei der Entwicklung eines pflanzlichen Arzneimittels aus Färberwaidextrakten 
eingesetzt werden.  
Ein umfangreiches, phytochemisches Profiling des pharmakologisch aktiven Isatis 
tinctoria Dichlormethanextraktes wurde durchgeführt. Die polaren Verbindungen in 
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I. tinctoria (MeOH Extrakt) und die taxonomisch nah verwandte TCM Pflanze 
I. indigotica wurden für Vergleichszwecke ebenfalls untersucht. Verschiedene 
Detektoren wie PDA, ELSD, APCI- and ESI-MS und ESI-TOF-MS wurden dabei parallel 
eingesetzt um eine möglichst groβe Auswahl von strukturell unterschiedlichen 
Sekundärmetaboliten abzudecken. Ausserdem kam eine neuartige NMR Technologie 
mit Mikroprobenkopf zum Einsatz, die die Strukturaufklärung einiger Minorverbindungen 
nach semi-preparativer Auftrennung ermöglichte. Die Strukturen von mehr als 75 
Verbindungen aus zahlreichen Strukturklassen wie bespielsweise Alkaloiden, 
Flavonoiden, Fettsäuren, Porphyrinen, Lignanen, Carotinoiden, Glucosinolaten und 
Cyclohexenonen wurden zweifelsfrei aufgeklärt und für einige weitere Verbindungen 
konnten Strukturvorschläge getroffen werden. Neben zahlreichen in der Gattung Isatis 
bisher unbekannten Stoffen wurde dabei auch ein neues Indolalkaloid entdeckt. 
Der Gehalt an Indolglucosinolaten in Waid und deren mögliche Rolle als Vorstufe für 
das Alkaloid Tryptanthrin wurde untersucht. Zuerst wurde eine HPLC-MS Methode für 
die quantitative Bestimmung der Glucosinolate entwickelt und validiert. Der Einsatz 
eines flüchtigen Ionenpaarreagenzes ermöglichte die Direktbestimmung der 
Glucosinolate. Die Extraktion mittels Hochdruckflüssigextraktion wurde optimiert und die 
Reinheit der Referenzsubstanzen wurde mit Hilfe einer quantitativen 1H-NMR Methode 
bestimmt.  
Saisonale Schwankungen des Glucosinolatgehaltes in Blättern von fünf definierten 
I. tinctoria Kulturen sowie einer I. indigotica Varietät wurden untersucht. Beim direkten 
Vergleich beider Arten waren signifikante qualitative und quantitative Veränderungen 
der Glucosinolatmuster festzustellen, während die Unterschiede innerhalb der 
verschiedenen I. tinctoria Stämme deutlich kleiner waren. Die Wiederholung der Ernte 
während der Wachstumsperiode hatte keine deutliche Auswirkung auf den Gehalt der 
Glucosinolate in nachwachsenden Blättern. 
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Wir untersuchten den Einfluss des Trocknungsverfahrens auf den Glucosinolatgehalt. 
Im Gegensatz zu den schockgefrorenen Proben konnten wir keine Glucosinolate in 
Pflanzenmaterial finden, das zuvor bei Raumtemperatur oder bei 40 °C getrocknet 
wurde. Allerdings konnten auch keine bekannten Abbauprodukte der Indolglucosinolate 
identifiziert werden.  
Die Glucosinolatmuster in Samen von fünf definierten I. tinctoria und zwei I. indigotica 
Kulturen wurden ebenfalls untersucht. Dabei wurden in den Samen deutliche 
Unterschiede im Vergleich zu den Blättern festgestellt. Qualitative und quantitative 
Unterschiede zwischen beiden Isatis Arten wurden entdeckt, was eine Unterscheidung 
beider Arten bereits auf Ebene des Saatgutes ermöglicht. 
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1. AIM OF THE WORK 
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The potential of woad (Isatis tinctoria L., Brassicaceae) extracts as new active 
ingredient for anti-inflammatory phytopharmaceuticals was explored during the last 
years and is still ongoing. Tryptanthrin, γ-linolenic acid and an indolin-2-one derivative 
were shown to be active principles inhibiting cyclooxygenase-2 (COX-2), 
5-lipoxygenase (5-LOX), the expression of inducible nitric oxide synthase (iNOS), 
human neurophil elastase, and the release of histamine from mast cells. Indirubin 
inhibits inflammatory reactions in delayed-type hypersensitivity and is a potent inhibitor 
of cyclin-dependent kinase 5 (CDK5) and glycogen synthase kinase 3β (GSK3B), 
whereas indigo is a side product of indirubin formation from indigo precursors during the 
drying of woad. 
In contrast to the numerous pharmacological studies on woad and its constituents, 
comparably few analytical work had been performed. A range of suitable analytical tools 
are, however, needed for the quality control and optimization of breeding, post-harvest 
treatment etc. As a first step, a suitable HPLC method for the quantification of the 
pharmacologically active constituents and indigo should be developed and validated, to 
be used in quality control for herbal extract preparations based on woad. 
Besides the quantity of active compounds, the overall composition (fingerprint) of an 
extract is important in quality control of phytopharmaceuticals, since legal authorities 
consider the extract in its entirety as active ingredient even if specific activities can be 
attributed to single compounds.  A second aim was, therefore, to analyse the spectrum 
of extracted metabolites as comprehensively as reasonably possible, for the 
pharmacologically active lipophilic leaf extract of. I. tinctoria. This profiling study should 
be complemented with an analysis of polar metabolites, and a profiling of the closely 
related I. indigotica Fort. A detailed knowledge of the chemical composition of the active 
extract should provide some clues on the nature of the compounds responsible for the 
solubility enhancing effects observed in a previous microdialysis study. 
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Oberthür et al. (2004) observed that the phytochemical profile of woad underwent 
profound changes during post-harvest treatment. Indigo precursors largely disappeared, 
whereas the pharmacologically active tryptanthrin and indirubin were formed only during 
the drying process. The precursor molecules of tryptanthrin and indirubin remained, 
however, unknown. A systematic investigation of possible candidates is crucial to 
optimise cultivation and harvesting conditions in the development of a new herbal drug. 
Indole glucosinolates occur in rather high concentrations in fresh woad leaves and are 
thus possible precursors of these indole alkaloids. The second part of the metabolite 
profiling study should, therefore, focus on the indole glucosinolates in Isatis, and their 
role as putative precursors of tryptanthrin and other indole alkaloids.  
First, a robust method should be developed for the quantitative determination of 
glucosinolates. Relevant parameters for sample preparation, extraction and analysis 
should be optimised and validated. Required reference compounds, which are not 
commercially available, should be isolated and their purity should be determined with a 
suitable procedure.  
The developed method should then be used to investigate seasonal fluctuations of 
glucosinolate patterns in leaves of defined Isatis accessions. Furthermore, the effects of 
repeated harvesting during the growth season and the influence of the drying procedure 
on the glucosinolate content should be examined. The glucosinolate patterns in seeds 
of defined I. tinctoria and I. indigotica strains should be analysed for comparative 
purposes.  
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2. INTRODUCTION 
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2.1 Woad (Isatis tinctoria L.) 
 
Historical background of woad as source of indigo  
Woad (Isatis tinctoria L., Brassicaceae) has a long and well documented history as an 
indigo dye plant and as a medicinal herb. This biennial herbaceous plant has been 
known in Central Europe for centuries. From the Middle Ages up to the 18th century, the 
cultivation of woad played an important economical role in certain parts of Europe. 
Centres of indigo production were located in 
Germany (especially in Thuringia) as well as 
in France (Normandy, Languedoc, Somme), 
England (Somerset, Lincolnshire) and Italy 
(Piedmont, Tuscany). The import of cheaper 
indigo from Indigofera suffruticosa initiated 
the decline of the woad industry in the late 
17th century and  woad cultures disappeared 
completely with the production of synthetic 
indigo in the late 1890’s1,2. 
 Figure 1. Traditional woad mill in Thuringia.  
(Illustration: 17th century) Source: Hurry2 
 
Medicinal uses, phytochemistry and biological activities of woad 
The medicinal properties of the plant were esteemed in Europe and in Traditional 
Chinese Medicine (TCM) for centuries. The application of woad for the treatment of 
wounds, ulcers and haemorrhoids was described by Hippokrates (460 B.C.), Galen 
(129-216 A.D.) and Pliny (23-79 A.D.). During the late Middle Ages Isatis was used to 
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treat snake bites, wounds and other inflammatory ailments. Its curative properties fell 
into oblivion after woad lost its importance as source of indigo for dying in Europe2.  
In China, Banlangen (Isatis root) and Daqingye (Isatis leaf) from the taxonomically 
closely related Isatis indigotica Fort. are still important and popular herbal drugs in 
Traditional Chinese Medicine (TCM) used for the treatment of inflammation, fever or 
swelling and are official drugs of the Chinese Pharmacopoeia up to the present time. 
Antibacterial and antiviral properties have also been described3. 
A considerable number of phytochemical, biological and pharmacological investigations 
have been carried out, mostly over the last 4 decades. More than 100 secondary 
metabolites have been identified from I. tinctoria and I. indigotica. They include 
numerous indole derivatives like tryptanthrin4 (1), indirubin5 (2), indigo5,6 (3), indolinone7 
(4), deoxivasicinone8 (5), or the indigo precursors isatan A (6) and isatan B9 (7), but also 
aliphatic and indolic glucosinolates10-13, aromatic and aliphatic carboxylic acids14,15, 
aliphatic alcohols, esters, ethers, aldehydes, hydrocarbons, nitriles and furans15,16, 
lignans17, various glycosides18,19, amino acids20,21, isoprenoids15,18, flavonoids8,22,23, 
sphingolipids24 and anthranoids8 (Figure 2).  
 
Figure 2: Structures of compounds 1-8. 
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Tryptanthrin (1) was originally isolated by Honda et al.4 as an anti-dermatophytic 
compound. High antimycobacterial activity of the compound and some derivatives was 
observed against Mycobacterium smegmatis in several in vitro studies25-27  but a 
notable in vivo efficacy was lacking28.  An aqueous extract of woad was tested in a 
chronic pulmonary infection model in rats. The observed effect was positive and was 
deemed promising for human studies29. Furthermore, its applicability was investigated in 
the context of the development of wood protecting varnishes. Fermented woad juice 
inhibited wood rotting fungi30 and weak insecticidal activity was found for 
tryptanthrin31 (1).  
Isatis extracts and selected constituents were screened for antiviral, antifungal, 
antibacterial and cytoinhibitory activities. However, its potential as an anti-inflammatory 
was not discovered at that time. Some years ago, a broad-based pharmacological 
screening was initiated and tryptanthrin (1), γ-linoleic acid (8) and (E)-3-(3',5'-dimethoxy-
4'-hydroxy-benzylidene)-2-indolinone (4) were shown to inhibit cyclooxygenase-2 (COX-
2), 5-lipoxygenase (5-LOX), expression of inducible nitric oxide synthase (iNOS), 
human neutrophil elastase and the release of histamine from mast cells32-36.  
Leclerc et al.37 found that indirubin (2) inhibits inflammatory reactions in delayed type 
hypersensitivity and is a potent inhibitor of cyclin-dependent kinase 5 (CDK5) and 
glycogen kinase 3β (GSK3B). These findings were corroborated by pharmacological 
studies on tryptanthrin (1) and indirubin (2) performed by other groups4,38-40. A clinical 
pilot study in experimentally induced skin erythema41 and in vivo studies in models of 
acute and chronic inflammation, contact allergy, and rheumatoid arthritis confirmed the 
anti-inflammatory activity of lipophilic Isatis tinctoria extracts42,43.  
Parallel to these pharmacological investigations, advanced phytochemical and 
analytical studies of the plant have been carried out. Oberthür et al. identified the 
correct structures of the major indigo precursors (6 and 7) in woad and observed 
profound post-harvest changes in metabolite patterns during the drying of Isatis leaves9. 
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Indigo precursors largely disappear, whereas pharmacologically active compounds such 
as tryptanthrin (1) were formed during the drying process44. However, the precursor 
molecules of tryptanthrin (1) or indirubin (2) are so far unknown and a systematic 
investigation of possible candidates is essential to optimise cultivation and harvesting 
conditions in order to establish a new herbal drug. 
 
Figure 3. Experimental research plots with Isatis plants  
at the Agricultural research station of Thuringia, Dornburg.  
 
The clinical efficacy of Isatis extracts can not be explained solely by the presence of 
individual active compounds like tryptanthrin (1), indirubin (2) and (E)-3-(3',5'-
dimethoxy-4'-hydroxy-benzylidene)-2-indolinone (4) because these compounds occur in 
too low amounts. Synergistic effects between extract constituents seem to play a central 
role and/or compounds in the complex extract matrix presumably increase the solubility 
of these poorly soluble alkaloids.  
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2.2 Interaction and synergy in phytomedicines 
Commonly, plant extracts are very complex mixtures, whose individual constituents are 
known only to a limited extent. The extracted compounds can be divided into main 
active substances and concomitant compounds. Pharmacologically active main 
compounds are responsible for the therapeutic effect of the extract, while concomitant 
compounds can change physico-chemical properties and therefore influence 
biopharmaceutical parameters like solubility and bioavailability of the main active 
substances.   
Several factors like conditions of cultivation, harvest, drying or storage, but also the 
selection of an appropriate extraction method, particle size, solvent and extraction 
duration have a major impact on composition and concentration of active compounds in 
an extract. As a general rule, the extract yield increases with the polarity of the solvent 
or solvent mixture used. This results in a lower drug-to-extract ratio45-47.  
The pharmacological activity of plant extracts is often not attributable to a single 
compound, and interactions between the extracts constituents have to be expected. In 
fact, proponents of phytotherapy consider the occurrence of synergistic effects in herbal 
extracts as a major advantage of this type of medicines. However, surprisingly few 
studies have been carried out to understand synergistic effects and interactions 
between plant constituents.  
 
Synergistic interactions between plant constituents  
Synergistic interactions have been described for constituents from an extract of a single 
plant, as well as for those from different plants in a multi-herbal formulation. The general 
understanding of synergy is that an effect of a combination of substances is greater 
than what can be expected from the sum of their individual contributions48,49. For 
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example, Wagner et al. found that isolated ginkgolides A and B from Ginkgo biloba L. 
were pharmacologically less effective as anti-inflammatory agents in vitro than a mixture 
of the two compounds50. Another case of synergistic interactions was described for 
Piper methysticum G. Forst (Kava-Kava), where the anticonvulsant activity of the kava 
lactones yangonin and desmethoxyyangonin was found to be much higher in 
combination with other kava constituents51. Keledjian et al. investigated the absorption 
of the kava lactones dihydrokavain, kavain, desmethoxyyangonin and yangonin in mice. 
The authors found higher concentrations of yangonin and kavain in the brain after 
administration of an extract compared to the equivalent amount of pure compounds52. 
Similar observations were described by Nahrstedt for kavain. After oral administration of 
pure kavain to mice the plasma concentration was more than 50% lower compared than 
that found after administration of the same amount of kavain in a refined Piper 
methysticum extract53. 
Flavonoids are present in many phytomedicines but their role as synergistic compounds 
is still not clear. Philippson observed that the activity of artemisinin in an in vitro 
antimalarial test was enhanced in the presence of the flavonoids artemetin and 
casticin54. Flavonoids were also involved in synergistic effects observed in a clinical trial 
with willow bark (Salix alba L.) for the treatment of ostheo-arthritis. According to the 
work of Schmidt et al., the applied amount of salicin (240 mg daily) was too low to 
explain the observed activity. Interestingly, gastrointestinal side effects associated with 
non-steroidal anti-inflammatory drugs such as acetylsalicylic acid were not observed, 
although it is known that the salicylalcohol derivative salicin is transformed in the liver 
into salicylic acid55.  
Butterweck et al. investigated the mode of action of St. Johns Wort (Hypericum 
perforatum L.) which is used for the treatment of mild forms of depression. Several 
compounds were isolated from the plant and used for an in vitro screening on several 
receptors, transporters and ion channels. Synergistic interactions between different 
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compounds were observed, and the authors concluded that this effect is responsible for 
the antidepressant activity in St. Johns wort56.  
 
Interaction by solubility enhancement 
Solubility enhancing properties have been described for saponins. It is known, for 
example, that saponins from Ginseng lead to a pronounced enhancement of the 
solubility of saikosaponins in water57. Kimata et al. found a considerable solubility 
enhancement of saikosaponin A, (a triterpene saponin of Bupleuri radix) by the Ginseng 
saponin chikusetsusaponin V (a bidesmoside of the oleanolic acid type)58. The solubility 
of saikosaponin A in water can also be enhanced by glycyrrhizin and glycyrrhizin 30-β-
glucoside ester and glycyrrhizin-30-β-glucuronide ester59. Zhou et al. showed that the 
significant solubility enhancement of saicosaponin B in water in the presence of a 
ginseng-saponin mixture is caused by malonyl-ginsenosides.  No solubility enhancing 
effects were observed with neutral ginseng-saponins of the dammarane type. In 
contrast, solubility enhancing effects of malonyl-saponins were increased in the 
presence of dammarane saponins60.  
Schöpke and Bartlakowski studied solubility enhancing effects that single saponins or 
mixtures of saponins had on quercetin, which was used as a model compound with poor 
solubility in water. The authors found that the saponin mixture enhanced the solubility of 
quercetin far below the critical micelle concentration (CMC), while this effect was not 
observed with a single saponin61. This result indicates that solubility enhancement can 
not be explained completely by micellar solubilisation.  
Liquorice (Glycyrrhiza glabra L.) contains a large variety of saponins and is used in 
many mixtures in Chinese medicine as an agent with synergistic and solubility 
enhancing properties. For example, it potentiates the effect of the neuromuscular 
blocking agent paeoniflorin62. Schindler found that adding 10% glycyrrhizinic acid, the 
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major saponin in Glycyrrhiza glabra, to am aqueous medium can enhance the solubility 
of the sapogenin isoliquiritigenin by a factor of 57063.  
However, a further systematic investigation of solubility enhancing effects of saponins 
has not been carried out so far.  
 
Solubility enhancing effects observed in Isatis 
Solubility enhancing effects were also found for Isatis tinctoria. The skin penetration of 
pharmacologically active tryptanthrin (1) from solutions of pure compound and lipophilic 
Isatis leaf extracts was investigated with a microdialysis study using an ex vivo pig 
foreleg model64. Tryptanthrin concentrations in the dialysates increased faster when the 
alkaloid was applied in the extract matrix. When applied in pure solutions the alkaloid 
crystallised on the skin surface. One explanation for this was that extract constituents 
act as solubility enhancers and increase the cutaneous penetration of poorly soluble 
compounds like tryptanthrin. Also synergistic pharmacological effects from other 
constituents in the extract have to be taken into account when considering the in vivo 
activities reported. 
 
Negative aspects of compound interaction in plant extracts 
In general, synergistic effects are considered to be positive because lower doses have 
to be applied but also less desirable interactions have been reported48. The presence of 
tannins in an herbal drug, for example, can lead to lower absorption of proteins or 
alkaloids due to the formation of poorly soluble complexes65. In case of St. John’s wort 
(Hypericum perforatum), the induction of the cytochrome P450 enzyme systems may 
accelerate the metabolism of other drugs which finally results in blood levels that are too 
low for a therapeutic effect48.  
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Franz66 observed that polysaccharides can generate a hydrocolloid film in the 
gastrointestinal tract and hereby decrease the absorption of other compounds. An 
absorption lowering effect has also been described for resins, gum and pektins67.  
Due to the complex composition of most plant extracts, it was possible only in rare 
cases to unequivocally assign factors which are responsible for the solubility 
enhancement and higher dissolution rate of poorly soluble compounds. Several factors 
that influence synergistic effects may interfere with each other. So far, only a small 
number of examples have been investigated45,46,48, and a systematic investigation of 
this issue is still lacking.  
These selected examples of influences of concomitant compounds on the dissolution 
and absorption of active compounds show, that concomitant compounds should not be 
regarded as worthless. It is therefore right that legal authorities consider the extract in 
its entirety as active ingredient, even if the specific activity can only be attributed to 
single compounds. Besides the quantity of active compounds also the composition of an 
extract is important in quality control of phytopharmaceuticals. 
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2.3 The role of plant extracts in the pharmacopoeia, and aspects of 
      quality control 
 
Medicinal plants and plant-derived phytopharmaceuticals account for approx. 25% of 
prescribed medicines and approx. 50% of the market share in over-the-counter products 
in industrial countries68,69. Safety and efficacy of these products are a central issue for 
regulatory authorities like BfArM (Germany) or Swissmedic (Switzerland) and for 
manufacturers. Compulsory guidelines to guarantee the quality of medicinal products 
including all phytopharmaceuticals are specified in pharmacopoeias such as the 
European Pharmacopoeia, the British Pharmacopoeia or the US Pharmacopeia.     
 
Definitions by the European Pharmacopoeia 
If the active constituents of herbal extracts are not known, marker compounds are used 
for standardisation to guarantee a constant quality. The European Pharmacopoeia 
(PhEur 6.0) distinguishes between different types of extracts according to their type of 
marker compounds70.  
“Standardised extracts” are adjusted to a given content of constituents with known 
therapeutic activity within an acceptable tolerance. The amount of active ingredient is 
defined in the final product but the amount of native extract varies. “Quantified extracts” 
are adjusted to a defined range of pharmacologically active constituents, or else, to a 
limited concentration of toxicologically critical compounds. Such adjustments are made 
by blending batches of extracts.  
Production of quantified extracts is only possible in cases where toxicological or 
pharmacological data of marker compounds exist. Examples are Devils Claw dry 
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extracts (Harpagophyti extractum siccum), standardised Horse Chestnut dry extract 
(Hippocastani extractum siccum normatum) or St. John’s Wort dry extract (Hyperici 
herbae extractum siccum). 
“Other extracts” are essentially defined by their production process. Factors like herbal 
material, extraction conditions or extraction solvents are specified. Quantification of 
analytically relevant markers is carried out for each individual batch and the amount of 
extract per dose is constant.   
Often, marker compounds of pharmacological, toxicological or analytical relevance are 
used for quality control purposes. Examples for the selection of compounds with 
pharmacological activity as markers are oligomeric procyanidines in Hawthorn dry 
extract (Crataegi folii extractum siccum), hyperforin in St. John’s Wort dry extract 
(Hyperici herbae extractum siccum) or ginkgolides in standardised Ginko biloba dry 
extracts (Ginkgo extractum siccum normatum). Aristolochic acid in Traditional Chinese 
Medicine (TCM) plants or pyrrolizidine alkaloids in butterbur (Petasites hybridus L. 
Gaertn.) dry extracts are examples of toxicologically relevant markers. Increase and 
decrease of marker compounds with analytical relevance give information on the 
identity and purity of extracts or herbal drugs.  
A special kind of extract as defined by the European Pharmacopoeia is the so called 
“refined extract”. If the active compounds are known, it is possible to obtain such 
extracts by several enrichment steps to remove unwanted compounds. Techniques for 
the separation of complex mixtures are selective extraction and partitioning methods, for 
example liquid-liquid-extraction, adsorption techniques and precipitation procedures in 
combination with filtration. Especially precipitation steps are widely used in industrial 
scale to remove unwanted constituents like proteins, polyphenols or waxy compounds.   
Only for very few phytopharmaceuticals the global composition of the active ingredient 
(extract) has been analysed in a more comprehensive manner and data published. 
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Notable examples include the special extracts EGb 761 (derived from Ginkgo biloba 
leaves) and ZE 331 (obtained from Petasites hybridus leaves). Both examples are 
discussed in the following sections. 
 
Example: the refined Ginkgo biloba extract EGb 761 
One example for a refined extract is the Ginkgo biloba extract EGb 761, where some 
compound classes are enriched and others are depleted compared to their original 
proportions in the plant. This is achieved in a sophisticated multi step extraction 
procedure (Figure 4).  
 
ground Ginkgo
leaves
primary extract concentrate 1 solution
upper phaseconcentrate 2solutionfiltrate
aqueous 
concentrate
aqueous 
concentrate, 
purified
Ginkgo dry 
extract EGb 761
extraction with 
acetone-water 
(60:40)
concentration in vacuo 
up to 30% to 40% (w/w) 
content of solids
dilution with water (1:1), 
filtration 
addition of ammonium sulfate
liquid-liquid extraction with 
ethylmethylketone - acetone,
filtration, discard precipitate
concentration in vacuo 
up to 50% to 70% (w/w) 
content of solids
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to a content of solids of 
10% (w/w)
addition of a lead hydroxide 
acetate solution,
discard precipitate
liquid-liquid 
extraction 
with heptane
liquid-liquid extraction with 
methylethylketone-ethanol drying in vacuo
 
Figure 4. Simplified production scheme of the Ginkgo biloba extract EGb 761. Adapted from Hänsel and 
Spieβ71 with minor modifications. 
 
Compounds which are responsible for allergic reactions72-74 or serious mucosal 
disturbances75 such as ginkgolic acid derivatives are removed. An overview of 
compounds present in Ginkgo biloba leaves but not in EGb 761 is shown in Table 1. 
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Compounds, which are regarded as pharmacologically active like flavonol glycosides, 
ginkgolides and bilobalide can be enriched by this extraction procedure. According to 
DeFeudis76 about 2.5 kg of extract is obtained from 100 kg of Ginkgo leaves. The 
extract contains approximately 24% (w/w) flavonoid glycosides, 3.6% (w/w) ginkgolides, 
2.9% (w/w) bilobalide, 6.5% (w/w) proanthocyanidins and less than 1 ppm alkyl phenol 
compounds (ginkgolic acid derivatives). The final EGb 761 product is standardised to 
contain 24% flavonol glycosides and 6% terpene lactones (3.1% ginkgolides, 2.9% 
bilobalide) which is controlled analytically to ensure the consistency of its composition.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Composition of the Ginkgo biloba extract (50:1) EGb 761. 
Source: Hänsel and Spieβ71 
 
 
 
Example: the Petasites hybidus extract Ze 339  
An other example for a well characterised extract is the butterbur (Petasites hybridus) 
extract Ze 339 used for the treatment of allergic rhinitis. Careful selection of plant 
material for cultivation, study of harvest conditions and choice of an appropriate 
extraction method (the manufacturer used an extraction technique with subcritical  CO2) 
enable an enrichment of the pharmacologically active petasins (petasin, neo-petasin, 
iso-petasin, S-petasin, neo-S-petasin and iso-S-petasin), while toxic pyrrolizidine 
Compound class Content [%] 
Flavonol glycosides 24 
Terpene lactones, thereof 6 
Bilobalide 2.9 
Ginkgolides A, B and C 3.1
Oligomeric proanthocyanidines 5-10 
Carboxylic acids  
(among others 6-hydroxy-
kynurenic acid, vanllic acid, 
protocatechuic acid, p-
hydroxybenzoic acid) 
approx. 9 
Ginkgoles and ginkgolic acids 0.0005 
Biflavones 0.1 
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alkaloids (such as senecionine, integerrimine and their N-oxides) are absent from 
Ze 33977,78. The composition of the respective compound classes is shown in Table 2. 
  
Compound class Content 
[%] 
Sum of petasins including 
petasin, neo-petasin, iso-petasin, S-
petasin, neo-S-petasin, iso-S-petasin 
20.3 
Fatty acids (total) 40.2 
unsaturated cis-fatty acids 1.1 
poly-unsaturated cis-fatty acids 33.8 
unsaturated trans-fatty acids 0.0 
poly-unsaturated trans-fatty acids 5.3 
Aroma components 7.0 
Steroids/Phytosterols 1.2 
Pyrrolizidine-alkaloids n.d. 
Remaining substances 30 
apolar constituents without chromophors 6.9 
water 
    Table 2. Composition of the refined Petasites hybridus extract Ze 339. 
    n.d.: not detectable; Source: Brattsröm (2003)78  
 
 
Drawbacks of current methods 
Special care has to be taken for the quality control of raw and final formulated products 
due to their complex composition. Current methods such as TLC, HPLC-UV or GC-MS 
provide only a limited insight into the complexity of the samples and often show limited 
separation and detection capabilities owing to the physicochemical properties of the 
analytes under investigation (e.g. poor volatility, lack of chromophores etc.). These 
methods are adapted to fulfil control needs of regulatory authorities and pharmaceutical 
manufacturers to track known adulterations but unknown adulterations can be easily 
overlooked. As a consequence of the lack of efficient tools in quality control, large 
variations of phytopharmaceuticals can be found on the market. The analysis of 14 
commercially available feverfew samples showed that each batch had a characteristic 
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spectra profile and two of the batches were distinctly different from the other twelve79. 
Since the chemical composition of a phytopharmaceutical critically depends on the plant 
growth environment, harvesting conditions and used preparation methods, it is essential 
that quality control of phytomedicines takes these factors into account. It is therefore 
desirable to establish analytical methods, which are able to profile plant extracts in a 
holistic manner and to provide a means for standardisation and quality control of 
phytopharmaceuticals based on their entire composition without reference to “active” 
molecules.  
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2.4 Metabolite profiling and quality control of medicinal plants 
 
Terminology and definitions 
Several approaches like metabonomics, metabolomics or metabolomic profiling have 
been developed during the last years. All these techniques try to give detailed 
qualitative and quantitative metabolite overviews in organisms or extracts. 
Metabonomics is a systems oriented approach describing “the quantitative 
measurement of the dynamic multiparametric metabolic response of living systems to 
pathophysiological stimuli or genetic modification” as defined in 1999 by Nicholson et 
al.80 Metabolomics is defined as “a comprehensive analysis in which all the metabolites 
of a biological system are identified and quantified”81 while, in contrast, metabolic 
profiling is defined as an approach using predefined metabolites which are 
biogenetically closely related and limited in number 82. Hence metabolic profiling has to 
be considered as a biased approach. An overview on strategies for metabolic analysis 
has been given by Dunn and Ellis82 and is shown in Table 3. 
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Strategy Description 
 
Metabolomics 
 
Non-biased identification and quantification of all metabolites in a 
biological system. Sample preparation must not exclude metabolites, 
and selectivity and sensitivity of the analytical technique must be high 
 
Metabolite profiling 
 
Identification and quantification of a selected number of pre-defined 
metabolites, generally related to a specific metabolic pathway(s). 
Sample preparation and instrumentation are employed so to isolate 
those compounds of interest from possible matrix effects prior to 
detection, normally with chromatographic separation prior to 
detection with MS. In the pharmaceutical industry, this is widely used 
to study drug candidates, drug metabolic products and the effects of 
therapeutic treatments 
 
Metabolic fingerprinting 
 
High-throughput, rapid, global analysis of samples to provide sample   
classification. Quantification and metabolic identification are generally 
not employed. A screening tool to discriminate between samples of 
different biological status or origin. Sample preparation is simple and, 
as chromatographic separation is absent, rapid analysis times are 
small (normally 1 min or less) 
 
Metabolite target analysis 
 
Qualitative and quantitative analysis of one or a few metabolites 
related to a specific metabolic reaction. 
Extensive sample preparation and separation from other metabolites 
is required and this approach is especially employed when low limits 
of detection are required. Generally, chromatographic separation is 
used followed by sensitive MS or UV detection 
 
Metabonomics 
 
Evaluation of tissues and biological fluids for changes in endogenous 
metabolite levels that result from disease or therapeutic treatments 
        
       Table 3. Overview on strategies for metabolic analysis. 
       adapted from Dunn and Ellis82 with minor modifications. 
 
Analytical platforms utilized for metabolic profiling - general considerations 
These modern metabolic strategies have to cope with the enormous number of 
unknown compound structures. Therefore analytical techniques as HPLC-MS using 
MSn and high accuracy mass spectrometric detection, offline NMR and HPLC-NMR 
couplings are required for structure elucidation and identification of complex metabolite 
structures83. 
However, some issues need to be considered when working with these hyphenated 
techniques. In metabolomic analysis factors such as age, type of tissues, 
developmental stage, environmental conditions and harvesting time greatly affect the 
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metabolome obtained even from the same genotype. Therefore, the herbal material 
should be frozen directly after harvesting to avoid any change. The subsequent sample 
preparation procedure has to be carried out most carefully to avoid artefact formation. 
As metabolomics aims at comprehensive fingerprinting of all metabolites, the used 
extraction methods should cover all possible plant metabolites. Unfortunately, there is 
no single extraction method to achieve this goal because the polarity of the extraction 
solvent limits the range of compounds that can be extracted. Thus, it is indispensible to 
extract the plant material under investigation with different polar and non-polar solvents 
to cover a wide range of metabolites and to optimise the extraction procedure to 
achieve an exhaustive but non-destructive extraction. In this context, a denaturation of 
enzymes involved in metabolite alteration should be considered, which can be achieved 
by drying of the plant material before extraction (for example by freeze drying), storing, 
grinding and extraction at low temperatures, or by the choice of a denaturating 
extraction solvent. A sample transformation for example by pH shifts has to be excluded 
before analysis82.  
For HPLC-MS techniques, modifiers are added to the mobile phase to increase 
ionisation efficiency and care must be taken to keep the physicochemical characteristics 
of the final samples (as pH, ion strength) constant over the whole sample set. Ion 
suppression effects are another well known problem in mass spectrometry of complex 
biological matrices. This phenomenon leads to a decreased ion yield and is not 
necessarily constant over a chromatographic run. Therefore, care must be taken that 
analyte responses are not unpredictably influenced by this effect, if compounds from 
different samples should be quantified and compared. Ion suppression can be 
minimised with a suitable sample preparation procedure, together with optimisation of 
chromatographic separation conditions84,85. An enhanced chromatographic resolution 
can be achieved for example with recent technologies as ultra performance 
chromatographic systems (for example the Waters UPLC™ system). The method is 
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based on the application of very small particles (1.7 µm) at elevated pressure to achieve 
superior theoretical plate numbers and resolution. When applied to natural product 
analysis, UPLC showed great advantages compared to standard HPLC86,87  
For NMR based approaches, factors as the intrinsic pH of the extract, NMR probe 
temperature stability, and quality of the residual solvent suppression affect the 
robustness of the applied method. Imperfect sample preparation techniques might 
introduce inhomogeneities to NMR spectra as described by Defernez and Colquhoun88  
 
Mass spectrometric approaches for metabolite profiling 
Ionisation techniques 
Gas chromatographic and liquid chromatographic techniques have gained a 
considerable importance for metabolic analysis. Within the past years, different methods 
for ion formation and ion selection have been developed. The oldest and most 
frequently used ionisation technique is electron impact ionisation (EI). The analytes of 
interest have to be vaporized prior to ionization, and this technique is therefore 
commonly used in GC-MS analysis. Due to the high reproducibility of EI spectra, they 
are amenable to database searches.  Extensive databases such as the NIST database 
are available. Over the past two decades, ionisation techniques such as electrospray 
ionisation (ESI), atmospheric pressure chemical ionisation (APCI), or matrix-assisted 
laser desorption ionisation (MALDI) have been developed for the analysis of non-volatile 
and thermally labile compounds. In ESI, ions are generated from a liquid by the 
formation of highly charged droplets and their subsequent evaporation. ESI is probably 
the most used ionisation technique for a wide range of biological analytes. It can be 
used in combination with separation techniques as HPLC or CE, and is considered to 
be a soft ionisation technique which does not result in extensive fragmentation of 
molecular ions as observed in electron impact mass spectrometers. This is the reason 
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why direct metabolite identification is not possible by comparing ESI mass spectra. 
Also, ESI mass spectral libraries are not available as in the case for GC-MS.  
A common alternative to ESI is 
atmospheric pressure chemical 
ionisation (APCI). With APCI, the HPLC 
eluent is heated to temperatures of 
about 400 °C and sprayed with nitrogen 
into the source. The ionisation is 
initiated by a corona discharge of a 
needle followed by a complex reaction 
cascade leading to an efficient ionisation 
of analytes (Figure 5).       
Figure 5. Interface design of an APCI source.  
Illustration: Bruker Daltonics 
 
Typically, the gas phase ionisation from APCI generates more fragment ions relative to 
the parent ion than the liquid phase ionisation technique ESI. With APCI it is also 
possible to ionise weakly polar analytes not existing as preformed ions in solution with 
ESI. Thus, the two ionisation techniques are complementary. 
APCI is known for its sensitivity, robustness and reliability but is less useful for thermally 
labile compounds and requires some compound volatility. In contrast to ESI, APCI has 
the advantage of being less susceptible to matrix interferences from salts85,89-92. 
Unlike ESI or APCI in which analyte ions are produced continuously, ions in matrix-
assisted laser desorption ionisation (MALDI) are produced by pulsed-laser irradiation of 
a sample. The sample is co-crystallised with a solid matrix that can absorb a 
wavelength of light emitted by the laser. MALDI is the method of choice for high 
throughput analysis, since target plates loaded with hundreds of samples can be used. 
The major drawback of MALDI lies in the high degree of chemical noise as a result of 
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the required matrices, especially if low molecular weight compounds have to be 
analysed. Therefore, a complete and reproducible MALDI of a metabolic profiling 
sample still remains a challenge93.    
 
Mass analysers 
For metabolic profiling strategies, several low resolution (single or triple quadrupole and 
ion trap) and high resolution (time of flight, FT-ICR-MS, orbitrap) mass analysers are 
utilised (Figures 6 to 8). In low resolution instruments, quadrupoles were the most 
commonly used mass analysers in the past, particularly in combination with EI 
ionisation in GC-MS platforms. Their major drawback is their relatively slow scanning 
rate (<4000 u/s) in full scan mode, not suitable for modern high-speed separations with 
narrow peaks. Triple quadrupole mass spectrometers give more structural information 
on the target analyte by arrangement of three quadrupoles, whereas the second 
quadrupole is used as collision cell for a controlled ion fragmentation. This setup allows 
the combination of ion selection, ion reaction and ion scan processes. Another way to 
obtain structural information by controlled ion fragmentation (collision induced 
dissociation (CID)) is the application of an ion trap as mass analyser. Ions are “trapped” 
with these devices by electrodynamic focusing and can be forced to leave the trap by 
putting them in unstable orbits by increasing the voltage. Ion traps enable the possibility 
to perform MSn experiments, are robust and are relatively inexpensive compared to 
other mass spectrometric devices and are therefore widely used. Quantitative 
performance and dynamic range could be improved with the recently developed linear 
ion traps. 
Time-of-flight mass analysers provide high resolution mass data by the separation of 
ions based on their mass-to-charge dependent velocity. All ions are formed in the ion 
source and accelerated through a fixed potential and consequently small mass ions 
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arrive to the detector earlier than large mass ions with the same charge.  A combination 
of a TOF mass analyser with other mass spectrometric devices such as a second TOF, 
an ion tap or one or two quadrupoles (Q-TOF) enable exceptionally high scan rates (up 
to 106 u/s) in combination with high resolving power. These hybrid mass spectrometers 
are used for large scale routine metabolic profiling experiments82,85,89-92,94. 
 
Figure 6. Pictorial diagrams of the common beam mass analysers: 
a single focusing time-of-flight (TOF) mass analyser  
b double-focusing time-of-flight analyser  
c quadrupole mass analyser; Illustration from Glish and Vachet90 
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A different type of mass analyser is the Fourier transform ion cyclotron mass 
spectrometer (FT-ICR-MS) with an unmatched resolving power. The FT-ICR-MS uses a 
magnetic field and the ions oscillate around the magnetic field with a cyclotron 
frequency that is inversely related to the m/z. Very simplified, the cyclotrone frequencies 
of the ions trapped in the FT-ICR are measured and converted into m/z. Today’s 
electronic equipment is able to measure frequencies with extremely high precision and 
this translates to a very high mass resolution. The potential of FT-ICR-MS has been 
discussed in articles of Wang et al.95 or Ohta et al.96 Although the capabilities of FT-
ICR-MS are undeniable, one has to be aware of the considerable cost and effort to 
operate an instrument based on a high-powered multi Tesla magnet.  
 
 
 Figure 7. Pictorial diagrams of the common trapping mass analysers. 
a quadrupole ion trap  
b Fourier-transform ion-cyclotron resonance (FT-ICR)  
Illustration from Glish and Vachet90 
 
The latest development, the orbitrap, was introduced on the market in 2005 as an 
alternative system to the FT-ICR-MS. The hybrid instrument consists of a linear ion trap 
which is used to selectively fill an intermediate ion storage device (C-trap) with ions of 
interest which are subsequently injected into the orbitrap (Figure 8). This device uses 
image current detection and Fourier transform similar to the FT-ICR-MS but does not 
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require a superconducting magnet which significantly reduces costs and maintenance 
requirements97,98.  
 
API Ion source
Differential pumping 
Orbitrap
Linear Ion Trap C-Trap
 
Figure 8. Pictoral diagram of a commercially available LTQ-Orbitrap instrument. Illustration from 
Makarov et al.97 with minor modifications. 
 
MS coupling to separation techniques 
In theory, the optimal way to obtain a mass spectrum of all metabolites in a sample in 
an unbiased way would be the direct application into the MS instrument without any 
purification or separation. However, if working with complex biogenic matrices, this 
approach is associated not only with an enormous instrument maintenance as cleaning 
of ion source and transfer optics but also with several interferences due to unspecific 
matrix effects and ion suppression by competitive ionisation. Therefore, commonly a 
chromatographic separation (for example by HPLC, UPLC or GC) of the matrix is 
necessary prior mass spectrometric detection.  
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A complementary promising combination of a highly efficient separation technique and 
MS as detector is CE-MS. A wide range of analytes can be separated by capillary 
electrophoresis (CE) ranging from low-molecular weight compounds up to proteins99. 
However, the development of a robust CE-MS method is still challenging, since CE 
principally differs in theory and practice from HPLC and GC and only a few metabolic 
profiling studies have been carried out so far with this technique100-102.  
 
LC-MS in metabolite profiling and their application in quality control: some examples  
In recent years, significant advances in LC-based on-line mass spectroscopy opened 
new avenues for increasingly comprehensive analysis of plant extracts. These 
possibilities have been exploited in metabolite profiling studies in which plant secondary 
metabolism was investigated from various perspectives. However, given the enormous 
difficulties of a comprehensive analysis, these studies have been usually focused on a 
limited range of compound classes.  
The metabolite profile of the model plant Arabidopsis thaliana L. Heynh. has been 
investigated quite intensively by LC-MS103-105. 
Dan et al. investigated the metabolite profile in different plant organs of Panax 
notoginseng Wall. The authors identified numerous saponins in flowers, roots and 
rhizomes using UPLC coupled to a quadrupole time-of-flight mass spectrometer106.  
Several authors developed HPLC-MS methods to investigate the composition of Ginkgo 
biloba preparations. For example Jensen et al.107 and Xie et al.108 used LC-APCI-MS 
methods to evaluate the contents of bilobalides and ginkgolides of commercial Ginkgo 
preparations while a capillary LC system coupled to an ion trap spectrometer was 
applied by Ding et al. for a fingerprinting of Ginkgo biloba preparations109. 
Artemisia annua L. is a potent drug for the treatment of malaria. The activity of the plant 
is ascribed to the sesquiterpenelactone artemisinin, which is very effective against drug-
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resistant plasmodium species110. In view of a possible use of an herbal preparation 
rather than the pure artemisinin, an HPLC-MS method was proposed for the 
identification and quantification of artemisinin and other constituents111.  An HPLC-
MS/MS method has been developed for a fingerprint profiling for seven different black 
cohosh (Cimicifuga) species and six different commercial products by Wang et al.112 
The validated method was utilised for a botanical identification of Cimicifuga species 
according to their triterpene glycoside patterns, and for quality control of black cohosh 
products. 
A HPLC system connected to a hybrid ion trap and time-of-flight mass spectrometer 
was used for the determination of flavanolignans in the hepatoprotective plant milk 
thristle (Silybum marianum L. Gaertn.). The authors proposed the application of this 
method as a general method for quality control of milk thistle products113.  
 
Nuclear magnetic resonance spectroscopy approaches for metabolite profiling 
General considerations 
As a tool for metabolic profiling, NMR has some unique advantages over MS-based 
methods. It can provide a detailed view on the molecular composition in relatively short 
time while relatively simple sample preparation is required. NMR is a universal detector 
for all molecules with NMR-active nuclei, unlike MS where detection of analytes is 
dependent on ionisation conditions or UV spectrometers where only chromophore 
bearing compounds are detectable84,114. In proton NMR spectroscopy (1H-NMR) the 
intensity of proton signals is proportional to the concentration of the metabolite. With the 
application of an internal standard, the real concentration of metabolites can be easy 
calculated115. Compared to modern mass spectrometry instrumentation, NMR 
spectroscopy is a rather insensitive analytical method but considerable effort has been 
conducted during the last years to overcome this issue. One major advantage of NMR 
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spectroscopy compared to other analytical techniques used for metabolite profiling is its 
matchless reproducibility and stability. A typical day to day variation often found with 
MS-based approaches is uncritical for NMR-based platforms85,114.  
 
Pattern recognition analysis in NMR fingerprinting  
The information content of NMR spectra is exceeding that of mass spectrometry by far 
because of the fact that each proton or carbon in a molecule gives a unique signal. 
Therefore multivariate computer-based pattern recognition methods have been 
developed during the last years to reduce the complexity of 1H-NMR profiles of herbal 
extracts. In this process spectra are analysed commonly after a data reduction step 
where each spectrum is digitised into integrated regions over fixed spectral intervals. 
After removal of solvent signals the spectra are normalised to the sum of the total 
spectral intensity to compensate differences in the amount of plant material analysed for 
each sample and the obtained data can be utilised for statistical analysis114 (Figure 9).  
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Figure 9. Schematic overview of the process of pattern recognition in complex biogenic matrices by a 
combination of NMR based metabonomics as discovery tool and modern hyphenated assays as analyte 
identification tools. Source: Holmes et al.114 
 
The potential of this approach for a possible application in quality control of 
phytomedicines has been demonstrated in a recent study by Rasmussen et al. The 
authors investigated nine commercially available products of St. John’s wort (Hypericum 
perforatum) by 1H-NMR in combination with multivariate analysis and found major 
variations to their global composition116. A similar study has been carried out by Seger 
et al. with seven crude drug lots of Hypericum perforatum. They used 1H-NMR 
fingerprinting with principal component analysis (PCA) and compared their results to 
those obtained by routinely used HPLC-DAD analysis and found that the discriminatory 
power between both methods was similar117.  
Bailey et al. investigated the composition of commercially available feverfew 
(Tanacetum parthenium L.) samples of several different manufacturers by high 
resolution NMR spectroscopy in combination with pattern recognition. A considerable 
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batch to batch variation was found even between products originating from the same 
manufacturer while a replication of experiments showed a high degree of reproducibility. 
They concluded that a better standardisation of these products is necessary79.  
NMR-based methods have also been applied to characterise extracts and 
phytopharmaceutical preparations of for example Arnica montana L.118, Artemisia 
annua111,119, Matricaria recutita L.120, Piper methysticum121, Cannabis sativa L. 122, 
Panax ginseng C. A. Mey.123, Angelica sp.124, Ephedra sp.125 and Ilex sp.126    
 
NMR Hyphenation: direct versus indirect techniques  
No analytical technique is suitable for the detection, identification and quantification of 
all metabolites in an herbal sample92. The most common strategy for structural 
determination is to isolate and identify metabolites, but additional options for structure 
elucidation have been developed in the last years. These include hyphenation of the 
NMR spectrometer to HPLC (as HPLC-NMR or HPLC-SPE-NMR). Such technologies 
employ a chromatographic work-up of the analysed mixture prior to the structural 
characterisation without time consuming and laborious preparative-scale isolation 
processes. This speeds up extract dereplication and helps to avoid re-isolation of 
already known extract constituents.  
“Continuous flow” (on-flow) experiments with direct coupling of the NMR spectrometer 
to a HPLC system were the first HPLC-NMR experiments to be done and are still 
frequently used to gain an overview of the metabolites present in an extract. The 
sensitivity of continuous flow methods is, however, limited by the short residence time of 
analytes in the NMR flow- cell, so the method is restricted to major components and 
only provides preliminary information.  
The “stopped-flow” NMR technique addresses this problem by stopping the flow of the 
HPLC pump as soon as a fraction of interest is inside the NMR flow cell. Stopped-flow 
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experiments enable much longer spectra acquisitions because analytes can be kept for 
a longer time in the NMR flow-cell. Even the acquisition of 2D experiments is possible, 
which is necessary for definitive structural assignments. One major disadvantage of 
stopped-flow measurements is a diffusion-mediated band broadening of analytes on the 
HPLC column. This effect results in a substantial decrease of concentration within the 
elution bands and closely spaced peaks can merge. An analyte eluting as a large peak 
may further contaminate the following minor peaks because of the peak-broadening 
effect of the NMR flow cell.  
In order to avoid these problems, a peak storage device for HPLC-NMR has been 
introduced that directs individual chromatographic peaks into capillary loops, where they 
are sealed and can be subsequently transferred into the NMR-flow probe. An advantage 
of this “loop storage” is that only minimal peak broadening occurs since the loops are 
made of capillaries and not of cavities like NMR flow-cells. Collected fractions can be 
measured in the NMR system as long as necessary and the flow cell can be washed 
between the transfer of individual peaks to avoid cross-contamination of analytes. 
Although the acquisition of NMR spectra is chronologically disconnected from the 
chromatographic separation, the NMR data are still obtained in the solvents used for 
HPLC separation. Therefore, the loop storage technique can be regarded as 
intermediate between direct and indirect hyphenated HPLC-NMR methods. 
An alternative is the recently introduced HPLC-SPE-NMR technique, where HPLC 
peaks are collected on solid phase extraction (SPE) cartridges in order to remove the 
analyte from the HPLC mobile phase, followed by an elution with deuterated solvents. 
This indirect HPLC-NMR hyphenation offers numerous advantages compared to direct 
HPLC-NMR methods. The purified HPLC fractions typically elute in very small solvent 
volumes and are therefore highly concentrated. Moreover, the whole chromatography 
can be run with regular protic solvents, and deuterated solvents are only required for 
elution from the cartridge. Multiple trapping leads to an increase of analyte amounts 
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available for NMR, enabling acquisition of high-quality 2D NMR data within a short time. 
Working with this technology also has its difficulties. A prerequisite for a successful 
operation of the HPLC-SPE-NMR system is that the analyte is quantitatively retained on 
and eluted from the SPE cartridge. Selection of the appropriate SPE material and 
eluting conditions can be challenging especially for unknown compounds and needs to 
be optimised127.   
An overview on these HPLC-NMR transfer methods is given in Figure 10 and numerous 
examples of identified plant metabolites were discussed in recent reviews128-133 
. 
 
Figure 10: Various LC-NMR coupled techniques. Illustration from Bross-Walch et al.132 
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A different approach is the development of specially designed microliter NMR probes as 
the 1 mm triple resonance (TXI) (1H,13C,15N) probe recently introduced into the market 
by Bruker. This probe has been especially developed for the structural characterisation 
of mass and volume limited samples such as natural products and allows the 
measurement of 1D 1H-NMR or 2D and 3D inverse heteronuclear NMR experiments 
with a few micrograms of sample. Here a single glass capillary tube for each individual 
sample is used in contrast to previously described directly coupled HPLC-NMR 
systems. NMR capillaries with microfractionated LC peaks can easily be collected and 
efficiently measured with the TXI probe using NMR automation and sample changing 
routines. This off-line approach offers some additional benefits, for example that 
potential dead volume effects caused by long transfer capillaries are minimised, and 
those caused by valve switching and fluidic problems are eliminated. LC peak dilution is 
kept to an absolute minimum, which is crucial for obtaining 
an optimal signal-to-noise ratio of mass-limited samples. 
The size difference between a conventional 5 mm NMR 
tube and a 1 mm capillary tube is shown in Figure 11.   
Figure 11: The 1 mm capillary tube (right) allows to identify structures 
from compounds in microgram range due to a higher sensitivity as 
result of a sample up-concentration (solvent volume approximately 5 µl). The standard NMR tube with an 
average sample volume of 500 µl is shown on the left side. 
 
The enormous potential of this 1 mm microliter probe has been demonstrated recently. 
Schlotterbeck et al. found an increase in mass sensitivity by a factor of five, which 
corresponds to a 25 fold reduction in measuring time of the same sample amount 
compared to a conventional 5 mm probe134. Furthermore, the amount of expensive 
deuterated solvent could be reduced by a factor of 100. Griffin et al. used the 1 mm 
probe for a metabolic profiling of biological fluids from rats and mice. An active volume 
of 2 µl was used to acquire 1H-NMR spectra of rat blood plasma and both rat and 
mouse cerebral spinal fluids - a volume which was easily removed without a required 
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termination of the animal. Several 1D and 2D experiments with different solvent 
presaturation sequences allowed the identification of numerous compounds, which 
finally allowed conclusions about the distribution of metabolites between blood plasma 
and cerebrospinal fluids135.   
 
HPLC coupling to mass spectrometry and NMR techniques: some examples 
When considering advantages and disadvantages of NMR and MS technologies, it 
becomes obvious that both strategies are complementary since different analyte 
concentrations and analyte classes are addressed. A combination of these 
complementary techniques in a single setup coupled to HPLC has been described by 
Hostettmann et al. (Figure 12). The authors demonstrated the advantages of this 
powerful tool in extract screening for new antifungal agents and for the investigation of 
polyphenols in Gentianaceae species with monoamine-oxidase inhibitory (IMAO) 
properties136,137.  
 
Figure 12: Schematic representation of an experimental setup used for  
LC-UV-MS-NMR analyses. Source: Hostettmann et al.137 
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Further studies with HPLC-MS-NMR-based methods have been carried out to identify 
substances from a variety of structural classes such as iridoid glycosides and phenyl 
propanoid glycosides from Harpagophytum procumbens Burch. DC ex. Meissn. (Devils 
claw)138,139, pyrrolizidine alkaloids from Senecio sp.140, iridoids from Jamesbrittenia 
fodina Wild O. M. Hilliard141,142, oxylipins from Arabidopsis thaliana143, carotenoids from 
Spinacia oleracea L. (spinach)144, furanocoumarins and quinoline alkaloids from 
Stauranthus perforatus Liebm.145. Various structures were identified from Hypericum 
perforatum146,147, Matricaria recutita (chamomile)148, Potamogeton sp.149,150, Terminalia 
macroptera Guill. & Perr. and Jasminum subtriplinerve Blume151.   
Bringmann et al. showed that it is possible to elucidate the complete structure (including 
absolute configuration) of novel secondary plant metabolites directly from the extract 
matrix without a single isolation step. They used a variety of on-line spectroscopic 
measurements (HPLC coupled to MS, NMR and CD detection) and elucidated the 
structures of several naphtylisoquinoline alkaloids from from the tropical lianas 
Ancistrocladus griffithii Planch.152 and Habropetalum dawei (Hutch & Dalziel) Airy 
Shaw153.  However, the circular dichroism (CD) detector is relatively insensitive and has 
so far only been applied for very few examples in natural products structure elucidation 
like in case of the biarylic naphtylisoqunioline alkaloids which have strong CD effects. 
 
Other technology platforms in metabolite profiling 
Some years ago, Fourier transform infrared reflectance (FT-IR) spectroscopy has been 
introduced as a metabolic fingerprinting technique for the analysis of plant material.  
This analytical technology enables a rapid, non-destructive, high-throughput analysis of 
a diverse range of sample types with a minimum of sample preparation. The principle of 
FT-IR is based on the fact that chemical bonds absorb irradiated light at a specific 
wavelength and vibrate in a number of ways such as stretching or bending vibrations. 
55
  
Due to its holistic nature, FT-IR is able to detect a wide range of compound classes 
simultaneously, but it has, however, some drawbacks. IR absorption of water in 
samples under investigation is very intense and can lead to signal overlapping. 
Moreover, sensitivity and selectivity are lower compared to previously discussed 
methods. Gidman et al. successfully used FT-IR to investigate global metabolites 
changes as a result of plant-plant interferences154 and Johnson et al. used this 
technology for metabolic fingerprinting of salt-stressed tomatos155. Fourier transform 
infrared spectroscopy has been applied to metabolomic questions far more than either 
raman or near infrared reflectance (NIR) spectroscopy. In NIR predominantly overtones 
and combination vibrations are measured while FT-IR spectra gave much more 
information in terms of chemical content156. NIR analysis was used by Huck et al. for a 
quantification of trimethoxyflavones in Primula veris L. extracts157. 
A new strategy in metabolomics is to focus on a cellular level and to investigate the 
metabolic flux between tissues and cells. Schneider and Hölscher studied the 
metabolite profile in specialised cells of different Dilatris species by using laser 
microsection (LMS) for tissue cryosectioning in combination with NMR and compared 
these obtained results to those of a whole leaf extract. By the application of this 
technology the authors could demonstrate that some of the secondary metabolites are 
located only in specific cells158. A similar approach was carried out on stone cells of 
Norway spruce bark with a combination of LMS/NMR/MS159.  
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3.1  Quantification of active principles and pigments  
in leaf extracts of Isatis tinctoria by HPLC/UV/MS  
       (Mohn et al., Planta Med 2007; 73:151-156).  
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3.2  A comprehensive metabolite profiling of  
Isatis tinctoria leaf extracts 
       (Mohn et al., Phytochemistry; submitted for publication). 
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 Abstract 
A broad-based characterisation of a pharmacologically active dichloromethane 
extract from Isatis tinctoria leaves was carried out. For a comprehensive picture we 
also included the polar constituents of I. tinctoria (MeOH extract) and, for 
comparative purposes, the taxonomically closely related TCM plant I. indigotica. 
PDA, ELSD, APCI- and ESI-MS, and ESI-TOF-MS detectors were used in parallel to 
ensure a wide coverage of secondary metabolites with highly diverging analytical 
properties. Off-line microprobe NMR after peak purification by semi-preparative 
HPLC served for structure elucidation of some minor constituents.  
More than 65 compounds belonging to various structural classes such as alkaloids, 
flavonoids, fatty acids, porphyrins, lignans, carotenoids, glucosinolates and 
cyclohexenones were unambiguously identified, and tentative structures proposed for 
additional compounds. Numerous compounds were identified for the first time in the 
genus Isatis, and a new indolic alkaloid was discovered. 
 
Keywords: Isatis tinctoria, Isatis indigotica, Brassicaceae, Metabolite profile, LC-MS, 
Pressurised Liquid Extraction, offline LC-NMR 
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 1. Introduction 
 
Woad (Isatis tinctoria L., Brassicaceae) has been used in Central Europe since 
antiquity as indigo dye and as medicinal plant for the treatment of inflammatory 
diseases until it fell into oblivion due to import of cheaper indigo and, as a 
consequence, the disappearance of woad cultures (Hamburger 2003). In China, 
Banlangen (Isatis root) and Daqingye (Isatis leaf) from the taxonomically closely 
related Isatis indigotica Fort. remain until now important and popular herbal drugs in 
Traditional Chinese Medicine (TCM) for the treatment of inflammatory diseases. Over 
the past years, we have been exploring the potential of Isatis tinctoria extracts as 
new active ingredient for anti-inflammatory phytopharmaceuticals. As a starting point 
we confirmed the anti-inflammatory potential of lipophilic (CO2 and dichloromethane) 
I. tinctoria leaf extracts in a broad-based pharmacological screening (Hamburger, 
2003). With the aid of HPLC-based activity profiling (Potterat and Hamburger, 2006) 
we then identified several pharmacologically active metabolites in the extracts, such 
as tryptanthrin (13), α-linolenic acid (22) and (E)-3-(3',5'-dimethoxy-4'-hydroxy-
benzylidene)-2-indolinone (9) as inhibitors of cyclooxygenase-2, 5-lipoxygenase, 
expression of inducible nitric oxide synthase (iNOS), human neutrophil elastase, and 
release of histamine from mast cells (Danz et al., 2001; Danz et al., 2002; 
Hamburger et al., 2006; Oberthür et al., 2005; Rüster et al., 2004). These findings 
were corroborated by pharmacological studies on tryptanthrin (13) and indirubin (15) 
performed by other groups (Hoessel et al., 1999; Honda et al., 1980; Ishihara et al., 
2000; Kimoto et al., 1999). The potential of lipophilic Isatis tinctoria extracts was 
substantiated by in vivo studies in models of acute and chronic inflammation, contact 
allergy, and rheumatoid arthritis (Recio et al., 2006a, b), and by a clinical pilot study 
in experimentally induced skin erythema (Heinemann et al., 2004). With the aid of a 
skin microdialysis study, we demonstrated that in topical application the extract 
matrix had a solubilising and penetration enhancing effect on the poorly soluble 
alkaloid tryptanthrin (13) (Oberthür et al., 2003).     
Parallel to these pharmacological investigations, we identified the correct structure of 
the major indigo precursors in woad (Oberthür et al. 2004) and identified new flavone 
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 glycosides (Cheng et al., 2005). We analysed composition and seasonal variation of 
indigo precursors and glucosinolates in defined accessions of Isatis tinctoria and I. 
indigotica leaves and seeds, and investigated the influence of harvest regimen on the 
chemical composition of woad leaves (Oberthür et al., 2004; Mohn and Hamburger, 
2008; Mohn et al., 2008). We observed profound post-harvest changes in metabolite 
pattern during the drying of leaves, chiefly the virtual disappearance of glucosinolates 
and indigo precursors, and the appearance of tryptanthrin (13) (Oberthür and 
Hamburger, 2004), besides the well known post-harvest artefacts indigo (14) and 
indirubin (15). 
There is a difficulty with the chemical characterisation of herbal extracts used as 
phytomedicines. Regulatory agencies such as BfArM (Germany) or Swissmedic 
(Switzerland) consider the extract in its entiety as active ingredient. Manufacturers of 
phytomedicines often use active marker substances for quality control purposes. For 
very few phytopharmaceuticals, the global composition of the active ingredient 
(extract) has been analysed in a more comprehensive manner and data published. 
Notable examples include the special extracts EGb 761 (derived from Ginkgo biloba 
leaves) (Hänsel and Spieβ, 2004) and ZE 331 (obtained from Petasites hybridus 
leaves) (Brattström, 2003). However, the analyses include only a limited number of 
compound classes, and major portions of these extracts remain uncharacterised.  
In recent years, significant advances in LC-based on-line spectroscopy opened new 
avenues for increasingly comprehensive analysis of plant extracts. These possibilities 
have been exploited in metabolite profiling studies in which plant secondary 
metabolism was investigated from various perspectives (Burns et al., 2003; Dan et 
al., 2008; Ding et al, 2008; Iijima et al., 2008; Le Gall et al., 2005; Long et al., 2006; 
Qiao et al., 2008; Schliemann et al., 2008; Yamazaki et al., 2003). However, given 
the enormous difficulties of a comprehensive analysis, these studies have been 
usually focused on a limited range of compound classes.  
Here, we report on a broad-based characterisation of the pharmacologically active 
extract from Isatis tinctoria leaves, using multiple detection systems to ensure a wide 
coverage of secondary metabolites with highly diverging analytical properties. For a 
comprehensive picture we also included the polar constituents of I. tinctoria (MeOH 
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 extract) and, for comparative purposes, the taxonomically closely related TCM plant I. 
indigotica.  
 
2. Results  
2.1 Metabolite profile of Isatis dichloromethane extracts 
Isatis tinctoria and Isatis indigotica leaves were submitted to pressurised liquid 
extraction (PLE) using dichloromethane and methanol. The dichloromethane extract 
corresponded to the pharmacologically active lipophilic extract reported earlier 
(Hamburger, 2003). Extracts were analysed by HPLC-PDA-MS and HPLC-TOF-MS. 
An overview of identified compounds is given in Figure 1. Figure 2A shows the HPLC 
profile of an I. tinctoria dichloromethane extract on C18 column (HPLC system 1). For 
the characterisation of the pharmacologically active extract in its full complexity, we 
combined several detectors as PDA, ESI-MS and APCI-MS (positive and negative 
ion mode). The unspecific evaporative light scattering detector (ELSD) was used to 
ensure that all separated compounds were assigned with at least one mass 
spectrometric detection mode. Additional structural information was obtained by 
MS/MS experiments and by high-resolution mass spectra recorded by ESI-TOF-MS 
(traces are not shown in Figure 2A). An overview of all compounds identified in the 
dichloromethane extract, and molecular formulae and UV data of further compounds 
is given in Table 1. Compounds 1-4, 6-7, 9-10, 13-15, 18, 22-25, 29, 30, 33, 34 and 
37 were identified by analysis of on-line spectroscopic data and subsequent 
confirmation by co-chromatography with reference compounds.  
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Figure 1. Structures of compounds 1 to 65. Consecutive numbering is according to their 
chromatographic retention. Compounds designated with (symbol ∗) were not detectable in the crude 
extracts and were identified only after MPLC pre-fractionation. 
Compounds 5, 8, 20, 21, 26-28, 31, 32, 35 and 36 were identified on the basis of 
their UV data in combination with MSn, high resolution-MS, and literature data on their 
chromatographic retention (Terasaki et al., 2002; van Breemen et al., 1991; Canjura 
and Schwartz, 1991; de Rosso and Mercadante, 2007a, b). The alkaloids 5-
hydroxyoxindole (5), 3-(2’-carboxyphenyl)-quinazolin-4-on (8) and bisindigotin (21) 
have been described for I. tinctoria or I. indigotica before (Li et al., 2000; Wei et al., 
2005; Wu et al., 1997) while the unsaturated fatty acid ((7Z, 10Z, 13Z)-
hexadecatrienoic acid (20)) and the porphyrins 10-hydroxy-phaeophorbide (26), 
phaeophorbide a (27), its epimeric form phaeophorbide a’ (28) and 
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 pyrophaeophorbide a (31), and the lutein isomers (32), (35) und (36) are compounds 
that are widely occurring in higher plant families.   
 
 
Figure 2. HPLC profiles of Isatis tinctoria dichloromethane (A) and methanol (B) extracts recorded 
with UV, ELSD, and ESI-MS and APCI-MS detectors in positive and negative ion mode. Peak labelling 
designates unambiguously identified compounds, and compounds for which only partial structural 
information was obtained (UC1 to UC26). 
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 Additional peaks of interest which could not be identified by on-line spectroscopy and 
reference compounds were earmarked for small scale purification and off-line NMR 
analysis. The dichloromethane extract was separated by MPLC into seven fractions, 
and fractions 2 and 3 were separated by semi-preparative HPLC.  Collected peaks 
were submitted to NMR and TOF-MS analysis after removal of solvents. Structures 
of additional 12 compounds (11, 12, 16, 17, 19, 43, 60-65) were elucidated with this 
approach. NMR spectra of 60-62 were identical with those of available reference 
compounds. Other compounds were identified by comparison with literature data, 
e.g. syringic aldehyde (11) (Hiltunen et al., 2006), 16-hydroxy-9-oxo-(10E, 12E, 14E)- 
octadecatrienoic acid (12) (Yoshikawa et al., 1998) , 1-O-β-D-galactopyranosyl-3-O-
linolenylglycerol (16) (Hohmann et al., 1996), 9-hydroxy-(10E, 12Z, 15Z)-
octadecatrienoic acid (17) (McLean and Reynolds, 1996), 9-oxo-(10E, 12Z, 15Z)-
octadecatrienoic acid (19) (Koch et al., 2002), pinoresinol (63) (Xie et al., 2003) and 
6,9-dihydroxy-4,7-megastigmadien-3-one (65) (Cutillo et al., 2005) (configurations of 
hydroxyl groups for compounds 12 and 17, and absolute and relative configurations 
for compounds 63 and 65 were not determined). The separation of fraction 3 gave a 
peak at 48.5 min which was identified as a new compound, (2Z)-2-(1H-indol-
3ylmethylidene)-1,2-dihydro-3H-indol-3-one (64) (Fig.1). Its molecular formula was 
established as C17H12N2O by HR-ESI-MS (m/z 261.1031 ([M+H]+, calc. 261.1029). 
HSQC and HMBC spectra  (Fig. 2S) revealed that the 13C resonances of 16 carbons 
were in the range of 105 -153 ppm and indicated a highly aromatic character of 64. A 
carbonyl resonance appeared at δ 185.0 ppm. Two NH groups (δ 9.28 and 11.91) 
and ten additional protons were observed in the 1H-NMR spectrum. The signals at δ 
6.89 (H-5), 7.17 (H-7), 7.17 (H-5'), 7.22 (H-6'), 7.48 (H-6), 7.48 (H-7'), 7.57 (H-4), 
7.83 (H-4') were characteristic for two ortho-substituted benzene moieties, and two 
singulets at δ 7.07 (H-10) and 8.17 (H-2') indicated two additional double bonds. 1D-
TOCSY experiments were used for the determination of overlapping aromatic 
signals, while HSQC and HMBC correlations (Figure 3) were used for further 
structure assignments. 1D NOESY experiments indicated spacial proximity of H-1 
(9.28 ppm), H-10 (7.07 ppm) and H-2' (8.17 ppm) and, consequently, a Z-
configuration of the linkage of the two indole moieties in 64.  
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Figure 3. Structure of new indole alkaloid 64  
(2Z)-2-(1H-indol-3-ylmethylidene)-1,2-dihydro- 
3H-indol-3-one with key HMBC and NOESY  
correlations. 
 
Numerous compounds from the dichloromethane extract of I. tinctoria could be also 
detected in the closely related species I. indigotica. A complete list of identified 
compounds and HPLC profiles obtained with PDA, ELSD and MS detectors are given 
as supplementary data (Table 1S and Figure 1S).  
 
 
2.2 Profiling of Isatis methanol extracts 
In previous studies (Oberthür et al., 2004, Mohn et al., 2008), we had observed 
profound changes in the spectrum of polar metabolites in woad leaves during the 
drying process. Therefore, we carried out a profiling of the MeOH extracts following 
extraction with dichloromethane. The separation (HPLC system 2) of the I. tinctoria 
MeOH extract is shown in Figure 2B. With exception of peaks 38 and 47 (indican and 
glucobrassicin), the extract mainly contained flavone-O- and C-glycosides. 
Compounds 3, 38, 41, 44-47 were identified with the aid of spectroscopic data (Table 
2), and structures were confirmed by co-chromatography with reference substances.  
Characteristic MS/MS fragments in combination with UV and HRMS spectra, 
retention time and literature data were used for the identification of the flavone-di-C-
glycosides 39 and 40 and for compound 42 with O- and C-linked sugar moieties 
(Gattuso et al., 2006; Deng et al., 2008). No fragments corresponding to a cleavage 
of a hexosyl moiety ([M-162]+) were observed in the ESI-MS spectra of 39 and 40 
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 recorded in positive ion mode, but numerous small fragments resulting from two C-
glycosidic moieties. In contrast, the spectrum of 42 showed loss of an O-glycosidic 
hexosyl moiety, followed by a partial fragmentation of a C-linked hexosyl moiety in 
MS2 and MS3. These results are in agreement with literature reports (Gattuso et al., 
2006; Li and Claeys, 1994; Waridel et al., 2004; Wolfender et al., 2001) and own 
experiments with flavone O- and C-glycosides. Glucobrassicin (47) and indican (38) 
were the only glucosinolates and indigo precursors that could be detected.      
Semi-preparative isolation and NMR analysis of a peak at 35.0 min lead to the 
structure of N-formyl anthranilic acid (43), a compound which has been described for 
I. tinctoria by Hartleb (1994).  
The majority of compounds identified from the MeOH extract of I. tinctoria were also 
present in I. indigotica (Fig. 1S and Table 2S; supplementary data). Besides the 
absence of some unidentified minor compounds only N-formyl anthranlic acid (43) 
and glucobrassicin (47) were not detected in I. indigotica. Absence of the latter 
compound in I. indigotica leaves had already been observed (Mohn et al. 2008). 
 
2.3 Profiling of carotenoids 
Several carotenoids (32, 35 and 36) were detected in the dichloromethane extract of 
Isatis tinctoria and I. indigotica leaves. Extraction and separation conditions, 
however, were not optimal for analysis of these highly lipophilic metabolites. For a 
more comprehensive analysis of the carotenoid pattern in dried leaves, we used 
dedicated extraction and separation protocols (extraction with hexane / acetone (1:1) 
(Britton, 1995) and HPLC on a C30 column (de Rosso and Mercadante, 2007b)). A 
HPLC chromatogram is shown in Figure 4, and an overview of identified compounds 
and spectroscopic data is given in Table 3. Although only (all-E)-β-carotene (54) was 
available as reference compound, it was possible to identify other carotenoids (32, 
35, 36 and 48-55) by a combination of spectroscopic and chromatographic 
information, including  UV-vis spectra (λmax, relative intensities of absorption maxima, 
and presence/absence of an absorption band at approximately 330 nm indicative of 
cis-configured double bonds), elution order on a C30 column, APCI-MS and MS/MS 
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 data, and comparison with published literature (de Rosso and Mercadante, 2007a, b). 
The elution order for E- and Z- isomers has been described for lutein by Updike and 
Schwartz (2003), for violaxanthin by Meléndez-Martínez et al. (2007), and for β-
carotene by Jaime et al. (2007). 
 
  
 
 
 
 
 
 
Figure 4. Carotenoid profile of Isatis tinctoria hexane/acetone leaf extract.  
Peak labelling 32, 35, 36, and 48-55 designates characterised compounds. 
UC27 to UC30 are carotenoids which could not be unambiguously identified.   
 
The lipophilic chlorophyll degradation products phaeophytin b (56), phaeophytin a 
(57), pyrophaeophytin b (58) and pyrophaeophytin a (59) were detected, if no 
saponification procedure was carried out. Spectral properties (UV, MS and MS/MS 
data) and elution order of these compounds were in accord with previously published 
data (van Breemen et al., 1991; Canjura and Schwartz, 1991).     
 
3. Discussion and conclusion 
The purpose of this study was to analyse the spectrum of extracted metabolites as 
comprehensively as reasonably possible, for the pharmacologically active lipophilic 
leaf extract of Isatis tinctoria, and to complement this profiling study with an analysis 
of polar metabolites and the closely related I. indigotica. In total, 65 compounds 
belonging to various structural classes could be unambiguously identified, including 
alkaloids, flavone glycosides, glucosinolates and indigo precursors, fatty acids, 
porphyrins, carotenoids, lignans, cyclohexenones and phenylpropanoids.  Additional 
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 compounds could be assigned to specific compound classes, or earmarked on the 
basis of their molecular formula derived from ESI-TOF-MS data. Numerous 
compounds have been identified for the first time in the genus Isatis (compounds 11, 
12, 16-19, 26-28, 32, 35, 36, 39, 40, 48-59), and compound 64 is a new natural 
product. Compounds 2, 8, 20, 21, 31, 41, 46, 63 and 65 were known so far only for I. 
indigotica and are reported here for I. tinctoria.  
The example demonstrates that only the parallel use of multiple detectors and 
detection modes can adequately reveal the complexity of a plant extract. With a 
combination of PDA, ELSD, ESI- and APCI-MS in positive and negative ion modes, 
virtually all peaks could be detected with at least two independent detection modes, 
and molecular formula could be derived in a second step from ESI-TOF-MS data. For 
a number of peaks, UV-vis and MS data did not permit unambiguous structural 
assignment. This was, for example, the case with fatty acids, where location of 
functional groups and E/Z geometry of double bonds could not be established. Off-
line microprobe NMR after peak purification by semi-preparative HPLC proved to be 
complementary. For truly minor constituents, a rapid pre-fractionation of the extract 
by MPLC was necessary to render compounds detectable by LC-PDA-MS and 
amenable to semi-prep. purification for NMR spectroscopy. The power of this 
approach could be demonstrated by the identification of a new indole alkaloid in the 
dichloromethane extract. 
Analysis of the MeOH extract of Isatis tinctoria and I. indigotica corroborated previous 
observations of an nearly complete disapearance of labile indigo precursors isatan A 
and B, and of glucosinolates. These two compound classes together correspond to 
approx. 5% to 10% of dry weight of fresh Isatis leaves (Oberthür et al., 2004, Mohn et 
al. 2008). Only the rather stable indigo precursor indican (38) and small amounts of 
the major glucosinolate glucobrassicin (47) could be detected. Thus, the MeOH 
extract of dry leaves consisted mainly of flavone glycosides. In contrast to the notable 
differences in glucosinolate profiles (Mohn et al., 2008; Mohn and Hamburger, 2008), 
the flavonoid patterns of Isatis tinctoria and I. indigotica were rather similar 
qualitatively even though differing quantitatively. The drying of leaves has been 
shown to be a prerequisite for anti-inflammatory activity of woad extracts 
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 (Hamburger, 2003), and at least two of the known active compounds, tryptanthrin 
(13) and indirubin (15), are formed during the drying process. 
Taking the relative peak areas in the ELSD profile as a measure, one can estimate 
that approximately 90% of the dichloromethane extract could be assigned to 
particular compounds or compound classes, respectively. This is comparable or 
better than the state of knowledge for well-characterised special extracts, such as 
EGb 761 from Gingko biloba L. (Hänsel and Spieβ) and ZE 331 from Petasites 
hybridus L. (Brattström, 2003) which are active ingredients in well-known 
phytopharmaceuticals. However, in Isatis, pharmacologically active compounds (9, 
13, and 15) known so far amount to a small portion (3.6% (Mohn et al., 2007) of the 
total extract only, if one excludes linolenic acid (22). The promising activity of Isatis 
extract can be explained, in part, by the high potency of compounds such as 
tryptanthrin (13) and indirubin (15). However, we assume that additional compounds 
contribute to the pronounced in vivo activity of Isatis extracts (Recio et al., 2006a, b). 
Potential candidates are likely to be found among the minor alkaloids which form a 
highly complex pattern in the HPLC profile (chiefly peaks between 8 and 24 min in 
Fig. 1a, with high signal intensity in positive ion ESI-MS). The extract matrix mainly 
consists of fatty acid derivatives, porphyrins and carotenoids, which account for 
>70% of the extract as estimated from the ELSD trace. We assume that these 
compounds are responsible for increasing the solubility of poorly soluble alkaloids, a 
fact that was previously observed, directly and indirectly, in the skin penetration study 
and in the clinical pilot trial comparing tryptanthrin and Isatis extract (Heinemann et 
al., 2004; Oberthür et al., 2003). Synergistic effects of constituents in a herbal extract 
are thought to play a central role, as the low amounts of individual compounds would 
not explain clinical efficacy of these products (Williamson, 2001). However, 
experimental evidence in support of this central paradigm of phytotherapy is relatively 
scarce (Eder and Mehnert, 1998). In case of the lipophilic Isatis tinctoria extract, a 
combination of pharmacological synergies (through compounds acting on different 
targets involved in inflammation) and bioavailability enhancement (through solubility 
enhancement by the extract matrix) seems to occur. 
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 4. Experimental 
4.1 Chemicals and reference compounds  
Analytical grade solvents for extraction and HPLC grade solvents for chromatography 
were purchased from Scharlau (Barcelona, Spain). HPLC grade water was obtained 
by an EASY-pure II (Barnstead, Dubuque IA, USA) water purification system. 
Deuterated solvents were purchased from Armar Chemicals (Döttingen, Switzerland). 
Isatin (1), sinapic acid (6), ferulic acid (7), syringic aldehyde (11), indigo (14), linolenic 
acid (22), palmitoleic acid (24), linoleic acid (25), palmitic acid (29), oleic acid (30), 
stearic acid (33), eicosenoic acid (34), eicosanoic acid (37), indican (38), β-carotene 
(54), indole-3-carboxaldehyde (60), indole-3-acetonitrile (61), vanillin (62), butylated 
hydroxytoluene, butylated hydroxyanisole and formic acid were purchased from 
Sigma-Aldrich (Buchs, Switzerland). Isoscoparin (3), ursolic acid (23), isoorientin (41) 
and isovitexin (44) were from Extrasynthese (Genay, France), and α-lysolecithin (18) 
was from Alexis (Lausen, Switzerland). Deoxyvasicinone (2), indoxyl (4), 3-(4-
Hydroxy-3,5-dimethoxybenzylidene)-2-indolinone (9), isoindigo (10), tryptanthrin (13), 
indirubin (15) had been previously synthesised at the Institute of Pharmaceutical 
Biology, University of Jena according to published procedures (Hoessel et al., 1999; 
Friedländer and Roschdestwenski, 1915; Sun et al., 1998). Isovitexin-3''-O-β-D-
glucopyranoside (45), isoscoparin-3''-O-β-D-glucopyranoside (46) and glucobrassicin 
(47) were isolated and characterised as previously described (Cheng et al., 2005; 
Mohn et al., 2007).  
 
4.2 Plant material  
Leaf material of defined strains of I. tinctoria (“Thüringer Waid”), and Isatis indigotica 
was harvested on 15th September 2003 from first year plants (rosette stage). Plants 
were cultivated on experimental plots of the Agricultural Research Station of 
Thuringia (TLL), Dornburg, Germany as previously described (Mohn et al., 2008). 
Specimens of seeds from the strains are kept at the TLL, under accession numbers 
153/PG 1 (Thüringer Waid) and 153 PG 12 (Isatis indigotica).  
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4.3 Sample preparation and extraction 
Freshly harvested Isatis leaf material was cut into small pieces of 2-3 cm length and 
immediately shock frozen with liquid nitrogen. Prior to extraction, the leaves were 
dried in a thermostatted oven at 40 °C. Temperature, relative humidity and weight 
loss were monitored during the drying process. Constant weight was achieved after 
3-4 d. The dried leaf samples were stored at room temperature for a few days in 
brown glass bottles in the dark. Immediately before extraction, dried leaf material was 
ground with a ZM 1 ultracentrifugal mill (Retsch, Haan, Germany, with 0.75 mm 
Conidur sieve. Pressurised liquid extraction (PLE) of 1.0 g frozen and powdered 
samples was carried out with an ASE 200 instrument (Dionex, Sunnyvale, CA, USA) 
with attached solvent controller. Conditions for all extractions were as follows: 
extraction solvent: dichloromethane, temperature: 70 °C; 2 extraction cycles of 5 min; 
preheat time: 1 min; flush: 100% of cell volume; purge: 80 s with nitrogen; pressure: 
120 bar; 22 ml steel cartridges. The extracts of two extraction cycles were combined, 
and the same plant material was extracted with methanol under same conditions.  
 
4.4 HPLC conditions 
HPLC separations were carried out on an Agilent series 1100 system equipped with 
degasser, binary high pressure mixing pump, column thermostat and photodiode 
array (PDA) detector (Agilent Technologies; Waldbronn, Germany). A liquid handler 
215 (Gilson; Mettmenstetten, Switzerland) was used as autosampler. The HPLC was 
coupled to an Esquire 3000 plus ion trap mass spectrometer equipped with 
electrospray (ESI) or atmospheric pressure chemical ionisation (APCI) interface 
(Bruker Daltonics; Bremen, Germany). High resolution mass spectra were obtained 
on a micrOTOF ESI-MS system (Bruker Daltonics) connected to an Agilent 1100 
series HPLC. Data acquisition and processing was performed using HyStar 3.0 
software (Bruker Daltonics).  
Separation conditions for the dichloromethane extracts (HPLC system 1): SunFire 
C18 column (3.5 µm, 150 x 3.0 mm I.D., Waters, Milford, MA, USA) equipped with a 
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 guard column (20.0 x 3.0 mm I.D.); mobile phase A: water with formic acid 0.1%, 
mobile phase B: acetonitrile, flow rate: 0.5 ml / min, column temperature: 25.0 °C, 
sample injection volume: 10 µl, solvent composition: 5% B isocratic for 2 min, 5% to 
93% B in 30 min), 93% B isocratic for 17 min, 93% B to 100% B in 6 min. A split ratio 
of 1:3 was used with the ESI interface.  
An evaporative light scattering detector (ELSD series 2000, Alltech, Deerfield Il, USA) 
was coupled to the second splitter outlet. ELSD conditions were: nitrogen flow: 1.5 
l/min, impactor: on, temperature: 55 °C, detector gain: 8. 
Separation conditions for the MeOH extracts (HPLC system 2): same conditions as 
for HPLC system 1 but with the following solvent composition: 5% B for 2 min, 5% B 
to 18% B in 30 min, 18% B to 24% B in 28 min. 
Sample preparation for carotenoids and chlorophyll degradation products was carried 
out with an Isatis tinctoria dichloromethane extract according to a previously reported 
method (Britton, 1995), with some modfications: The extract was dried in vacuo and 
300 mg of the residue was re-dissolved in 100 ml of a mixture of acetone and hexane 
(1:1) containing butylated hydroxytoluene (62.5 mg/ 100 ml) and butylated 
hydroxyanisole (62.5 mg/ 100 ml). After filtration, the solution was transferred to a 
separatory funnel and 100 ml of a sodium chloride solution (10 g / 100 ml) was 
added. The suspension was shaken in a separatory funnel. After phase separation, 
the aqueous phase was discarded and the organic layer washed twice with water (2 x 
100 ml), dried with anhydrous sodium sulphate and evaporated in vacuo. For 
identification of the chlorophyll degradation products 56-59, the residue was 
dissolved in 2-propanol, filtered through a membrane filter (0.2 µm) prior to HPLC-MS 
analysis. For identification of carotenoids, chlorophyll had to be degraded by 
saponification. The residue was dissolved in 10 ml diethyl ether and mixed with 10 ml 
of methanolic KOH (10%). The flask was flushed with nitrogen and kept in the dark at 
ambient temperature for 3 h. The alkaline mixture was transferred to a separatory 
funnel containing 100 ml of diethyl ether. The organic solution was washed three 
times with water, dried with anhydrous sodium sulphate and evaporated to dryness. 
The residue was dissolved in mobile phase, filtered (0.2 µm) and analysed by HPLC-
MS. 
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 Separation conditions for the carotenoid separation (HPLC system 3) were adopted 
from de Rosso and Mercadante (2007a, b) using a YMC C30 column (3 µm, 150.0 x 
3.0 mm I.D.; Stagroma, Reinach, Switzerland) with guard column (10.0 x 3.0 mm 
I.D.) and a linear gradient of methanol / methyl-tert-butyl ether (MTBE).  
 
4.5 MS instrumentation and parameters 
Positive and negative ion LC-MS spectra on the ion trap instrument with electrospray 
ionisation (ESI) were recorded after optimisation of settings, under ion charge 
conditions (positive mode: ICC 30000; negative mode: ICC 20000) at a scan speed 
of 13000 m/z/s, using a gauss filter width of 0.2 m/z. Nitrogen was used as a drying 
gas at a flow rate of 10 l/min and as a nebulising gas at a pressure of 30 psi. The 
nebuliser temperature was set at 300 °C. Spectra were recorded in the range of m/z 
100 to 800. Capillary voltage was at -4500 V (negative mode: +4500 V), endplate 
offset at -500 V, capillary exit voltage at 111.8 V (negative mode: -111.8 V), skimmer 
voltage 40.0 V (negative mode: -40.0 V) and trap drive at 41.8. MSn experiments 
were performed on the quasimolecular ions [M+H]+ or [M-H]- using helium as collision 
gas. The isolation width was set to 4.0 m/z and the fragmentation amplitude was set 
to 1.00 V in the ‘smart fragmentation’ mode. 
Settings for APCI were as follows: Ion charge conditions (ICC 30000 positive mode; 
ICC 20000 negative mode), scan speed: 13000 m/z/s, gauss filter: 0.2 m/z, nitrogen 
as drying gas (flow rate 5 l/min) and nebulising gas (pressure: 30 psi), nebuliser 
temperature: 375 °C, drying temperature: 250 °C, scan range m/z 100 – 800 (for 
detection of carotenoids and porphyrins in the hexane/acetone extract: m/z 100 – 
1200), capillary voltage: -4500 V (negative mode: +4500 V), endplate offset: -500 V, 
capillary exit voltage: 128.5 V (negative mode: -128.5 V), skimmer voltage: 40 V 
(negative mode: -40 V), trap drive: 58.8 (negative mode: 61.4). For MSn experiments: 
‘smart fragmentation mode’, isolation width: 4.0 m/z, fragmentation amplitude: 1.00 
V, helium as collision gas.   
Conditions for LC–TOF-MS were as follows: spectra were recorded in the range of 
m/z 100–800 in positive and negative mode. Nitrogen was used as nebulising gas at 
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 a pressure of 2.0 bar and as drying gas at a flow rate of 9.0 l/min (dry gas 
temperature 240 °C). Capillary voltage was at -4500 V (+4500 V in negative mode), 
endplate offset at −500 V, hexapole at 250.0 Vpp (negative mode: 230 Vpp), 
skimmer 1 at 40 V (negative mode: −50 V) and skimmer 2 at 22.5 V (negative mode: 
−22.5 V). Instrument calibration was performed using a reference solution of sodium 
formate 0.1% in isopropanol/water (1:1) containing 5 mM sodium hydroxide. Typical 
mass accuracy was ± 2 ppm. 
 
4.6 Off-line semi-preparative HPLC-NMR analysis 
Powdered Isatis tinctoria leave material (400 g) was percolated with 600 ml petrol 
ether (boiling point 40-60 °C) followed by 2 l of dichloromethane to afford 14.5 g of 
dichloromethane extract. Pre-fractionation of the dichloromethane extract was carried 
out on a Sepacore MPLC system equipped with two pump modules C-605, UV 
photometer C-635, fraction collector C-660 and Sepacore record software (Büchi, 
Flawil, Switzerland). Due to poor solubility of the dichloromethane extract, 1 g of 
extract was adsorbed on 10 g C18 packing material and filled into an empty 
precolumn cartridge (120 x 17 mm I.D.). Adsorbed analytes were eluted onto a 
prepacked Sepacore C18 column (50 µm, 150 x 40 mm I.D) for separation. Conditions 
were as follows: mobile phase A: H2O, mobile phase B: MeOH, flow rate: 15 ml/min, 
mobile phase composition: 15% B isocratic for 2 min, 15% B to 85% B in 68 min, 
85% B to 100% B in 10 min, 100% B for 20 min. One fraction per minute was 
collected and appropriate fractions were combined (fractions 1-7). Fractions 2 (29.4 
mg) and 3 (32.6 mg) were selected for semi-preparative HPLC on a SunFire C18 
column, 5 µm, 150 x 10.0 mm I.D., (Waters, Milford, MA, USA) equipped with a guard 
column (10.0 x 10.0 mm I.D.). Separation conditions were as follows: mobile phase 
A: H2O with formic acid 0.1%, mobile phase B: MeOH, flow rate: 5 ml/min, column 
temperature: 25 °C, injection volume: 900 µl (corresponding to 15 mg of the 
respective fraction) dissolved in 5% B. Gradient for the separation of fraction 2 was: 
5% B for 2 min, 5% B to 65% B in 98 min, 65% B to 70% B in 10 min; gradient for the 
separation of fraction 3 was: 34% B for 13 min, 34% B to 85% B in 87 min.  
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 Conditions for the semi-preparative isolation of compound 43 from the methanol 
extract of Isatis tinctoria were identical as for HPLC system 2 with exception of 
column dimensions (SunFire C18, 5 µm, 150 x 10.0 mm I.D; Waters) and flow rate (5 
ml/min). Peak based collection was monitored at 210 nm. Mobile phase was removed 
by parallel evaporation (Genevac EZ-2, Genevac, Gardiner, NY, USA), and samples 
were submitted to LC-TOF-MS and NMR analysis.     
NMR spectra were obtained with a 500 MHz Avance III system (Bruker, Fällanden, 
Switzerland) equipped with a 1mm TXI probe. Data processing was with Topspin 2.1 
(Bruker). 
(2Z)-2-[1H-indol-3-ylmethylidene)-1,2-dihydro-3H-indol-3-one (64): orange film, UV 
(online, MeOH / 0.1% aq HCOOH) λmax = 269, 392 and 494 nm; ESI-HRMS, m/z 
261.1031 ([M+H]+, C17H12N2O, calc. 261.1029). ESI-MS, m/z (rel. int.): 261 [M+H]+, 
283 [M+Na]+; 1H-NMR (500 MHz, DMSO-d6): δ 6.89 (1H, dd, H-5, J4,5 = 7.4 Hz, J5,6 = 
7.4 Hz), 7.07 (1H, s, H-10), 7.17 (1H, d, H-7, J6,7 = 7.7 Hz), 7.17 (1H, dd, H-5', J4',5' = 
7.7 Hz, J5',6' = 7.7 Hz), 7.22 (1H, dd, H-6', J5',6' = 7.7 Hz, J6',7' = 7.7 Hz), 7.48 (1H, dd, 
H-6, J5,6 = 7.4 Hz, J6,7 = 7.7 Hz), 7.48 (1H, d, H-7', J6'7' = 7.7 Hz), 7.57 (1H, d, H-4, 
J4,5 = 7.7 Hz), 7.83 (1H, d, H-4', J4',5' = 7.7 Hz), 8.17 (1H, s, H-2'), 9.28 (1H, bs, H-1), 
11.91 (1H, bs, H-1'). 13C-NMR (extracted from 2D-HMBC and HSQC spectra): δ 
104.6 (C-10), 105.2 (C-3'), 112.5 (C-7'), 112.8 (C-7), 118.7 (C-4'), 119.6 (C-5), 120.8 
(C-5'), 121.4 (C-9), 122.9 (C-6'), 124.0 (C-9'), 127.6 (C-9'), 127.9 (C-2'), 135.2 (C-6'), 
135.6 (C-6), 136.6 (C-8'), 153.5 (C-2), 185.0 (C-3). 2D-NMR spectra of 64 are shown 
in Figure 2S (supplementary data). 
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 Tables 
Table 1. Compounds identified from dichloromethane extract of Isatis tinctoria leaves. 
Peak Rt (min) λmax (nm) ESI
+ ESI- APCI+ APCI- Acc. mass founda 
Acc. 
mass 
calc.a 
Assignment 
UC1 8.7 235; 310 337 [M+H]+ 335 [M-H]- 337 [M+H]+ 335 [M-H]- 337.1852 337.1838 C21H22N2O2 
UC2 10.8 240 fragments - - - n.d. - unknown 
UC3 11.3 207; 247; 300 297 [M+H]+ - - - n.d. - unknown 
1 11.8 209; 241; 303; 416 148 [M+H]+ - 148 [M+H]+ - 148.0406 148.0399 Isatin 
2 12.2 207; 226; 259; 
302; 313 
187 [M+H]+ - 187 [M+H]+ - 187.0868 187.0872 Deoxyvasicinone 
3 12.7 216; 270; 345 463 [M+H]+; 485 [M+Na]+ 461 [M-H]- 463 [M+H]+ 461 [M-H]- 463.1248 463.1241 Isoscoparin 
4 12.9 205; 248 134 [M+H]+ - 134 [M+H]+ - 134.0612 134.0607 Indoxyl 
5 13.2 258; 302 150 [M+H]+ 148 [M-H]- 150 [M+H]+ - 150.0552 150.0556 5-Hydroxyoxindole 
6 13.3 235; 322 225 [M+H]+ 223 [M-H]- - 223 [M-H]- 225.0758 225.0764 Sinapic acid 
7 14.0 238; 322 195 [M+H]+; 411 [2M+Na]+ 193 [M-H]- 195 [M+H]+ 193 [M-H]- 195.0653 195.0658 Ferulic acid 
UC4 15.0 309 517 [M+H]+ 515 [M-H]- 517 [M+H]+ 515 [M-H]- 517.1963 517.1976 C29H28N2O7 
8 15.3 220; 275; 309 267 [M+H]+ 265 [M-H]- 267 [M+H]+ 265 [M-H]- 267.0779 267.0770 3-(2'-Carboxyphenyl)-quinazolin-4-one 
UC5 15.8 316 501 [M+H]+ 499 [M-H]- 501 [M+H]+ 499 [M-H]- 501.2055 501.2067 C34H28O4 
UC6 17.8 - 351 [M+Na]+ 327 [M-H]- - 327 [M-H]- 327.2178 327.2171 C18H32O5 probably trihydroxyoctadienoic acid 
9 19.5 210; 258; 380 298 [M+H]+ - 298 [M+H]+ - 298.1087 298.1080 (E)-3-(3',5'-dimethoxy-4'-hydroxy-
benzylidene)-2-indolinone 
 10 19.8 203; 266; 391; 478 263 [M+H]+; - 263 [M+H]+ - 263.0828 263.0821 Isoindigo 
11 20.9 227; 307 183 [M+H]+; 205 [M+Na]+ - 183 [M+H]+ - 183.0657 183.0658 Syringic aldehyde 
12 21.0 309 309 [M+H]+; 331 [M+Na]+ 307 [M-H]- 309 [M+H]+ 307 [M+H]- 309.2064 309.2067 Corchorifatty acid B 
13 21.4 252; 311; 392 249 [M+H]+; 271 [M+Na]+ - 249 [M+H]+ - 249.0664 249.0665 Tryptanthrin 
UC7 22.0 260 267 [M+H]+ 265 [M-H]- - - n.d. - unknown 
14 23.2 243; 285; 606 263 [M+H]+; - 263 [M+H]+ - 263.0821 263.0821 Indigo 
UC8 23.8 - 699 [M+Na]+ 675 [M-H]- - 675 [M-H]- n.d. - unknown 
15 24.1 240; 290; 362; 541 263 [M+H]+, 285 [M+Na]+ - 263 [M+H]+ - 263.0829 263.0821 Indirubin 
16 26.4 - 537 [M+Na]+ 513 [M-H]- - 513 [M-H]- 513.3057 513.3063 1-O-β-D-galactopyranosyl-3-O-
linolenylglycerol 
17 26.7 240 317 [M+Na]+ 293 [M-H]- - 293 [M-H]- 293.2107 293.2116 9-Hydroxy-(10E, 12Z, 15Z)-octadecatrienoic 
acid 
18 27.1 - 496 [M+H]+; 518 [M+Na]+ - - - 496.3392 496.3404 α-Lysolecithin 
19 27.6 279 315 [M+Na]+ 291 [M-H]- - - 291.1953 291.1959 9-Oxo-(10E, 12Z, 15Z)-octadecatrienoic acid 
UC9 28.8 250 381 [M+H]+; 403 [M+Na]+ - 381 [M+H]+ - 381.1596 381.1604 C25H20N2O2 
UC10 29.8 - 509 [M+H]+; 531 [M+Na]+ 507 [M-H]- - - 509.3025 509.3016 C30H40N2O5 
20 30.7 - - 249 [M-H]- - 249 [M-H]- 249.1851 249.1854 (7Z, 10Z,13Z)-Hexadecatrienoic acid 
21 31.5 261; 351; 568 491 [M+H]+ 489 [M-H]- 491 [M+H]+ 489 [M-H]- 491.1506 491.1508 Bisindigotin 
UC11 32.8 - 672 - - - n.d. - unknown 
22 33.5 - 279 [M+H]+; 301 [M+Na]+ 277 [M-H]- 279 [M+H]+ 277 [M-H]- 277.2161 277.2167 Linolenic acid 
23 34.3 - 457 [M+H]+ 455 [M-H]- - - 457.3683 457.3682 Ursolic acid 
24 34.7 - - 253 [M-H]- - - 253.2182 253.2167 Palmitoleic acid 
 UC12 35.1 410; 664 563 [M+H]+ 561 [M-H]- 282 282 n.d. - unknown porphyrin derivative 
25 35.4 - - 279 [M-H]- - - 279.2321 279.2323 Linoleic acid 
26 35.8 325; 407; 505; 
533; 605; 664 
609 [M+H]+; 631 [M+Na]+ 607 [M-H]- - - 609.2723 609.2714 10-Hydroxy phaeophorbide 
27 36.5 320; 409; 505; 
534; 606; 664 
593 [M+H]+; 693 [M+Na]+ 591 [M-H]- 593 [M+H]+ 591 [M-H]- 593.2763 593.2765 Phaeophorbide a 
28 37.5 321; 408; 506; 
535; 606; 666 
593 [M+H]+; 693 [M+Na]+ 591 [M-H]- 593 [M+H]+ 591 [M-H]- 593.2768 593.2765 Phaeophorbide a' 
29 37.8 - - 255 [M-H]- - 255 [M-H]- 255.2316 255.2323 Palmitic acid 
30 38.3 - - 281 [M-H]- - 281 [M-H]- 281.2474 281.248 Oleic acid 
31 38.6 321; 410; 507; 
537; 606; 666 
535 [M+H]+ 533 [M-H]- 535 [M+H]+ 533 [M-H]- 535.2712 535.2710 Pyrophaeophorbide a 
32 41.0 420; 443; 470 569 [M+H]+ - 569 [M+H]+ 567 [M-H]- 569.4362 569.4359 (all-E)-Lutein 
33 43.3 - - 283 [M-H]- - - 283.2630 283.2636 Stearic acid 
34 43.5 - - 309 [M-H]- - - 309.2809 309.2793 Eicosenoic acid 
35 44.1 328; 416; 439; 465 - - 569 [M+H]+ - 569.4357 569.4359 (9Z)-Lutein 
36 45.0 328; 416; 440; 467 - - 569 [M+H]+ - 569.4361 569.4359 (9'Z)-Lutein 
UC13 49.0 - - 621 397 621 n.d. - unknown 
37 52.4 - - 311 [M-H]- - - 311.2970 311.2949 Eicosanoic acid 
UC14 52.7 - - - 855; 792 819 n.d. - unknown 
 
n.d. = not detected; a = found and calculated accurate mass for the respective [M+H]+ or [M-H]- ion; UC1 to UC 14 are compounds for which only partial structure information was 
obtained. 
 
 
 
  
Table 2. Compounds identified from methanol extract of Isatis tinctoria leaves. 
Peak Rt (min) λmax (nm) ESI
+ ESI- 
Acc. 
mass 
founda 
Acc. 
mass 
calc.a 
Assignment 
UC15 11.3 n.d. 337 [M+H]+ - 337.1852 337.1838 C21H24N2O2 
UC16 14.2 209; 253; 301 317 [M+H]+; 339 [M+Na]+ 315 [M-H]- 317.1131 317.1138 C16H16N2O5 unknown anthranilic acid derivative 
UC17 15.8 n.d. 307 [M+H]+ - 307.1745 307.1732 C20H22N2O 
UC18 16.5 n.d. 337 [M+H]+ - 337.1853 337.1838 C21H24N2O2 
UC1 17.6 236; 312 337 [M+H]+ - 337.1850 337.1838 C21H24N2O2 
38 18.3 222; 280 - 294 [M-H]- 294.0971 294.0977 Indican 
39 24.1 210; 269; 334 595 [M+H]+; 617 [M+Na]+ 593 [M-H]- 595.1652 595.1664 Vicenin-2 
UC19 24.5 238 409 [M+ H]+ 407 [M-H]- 409.1772 409.1764 C23H24N2O5 
UC20 25.2 213; 268; 330 757 [M+H]+; 779 [M+Na]+ 755 [M-H]- 757.2192 757.2191 C33H40O20 unknown flavone triglycoside with two C-linked and one O-linked 
hexosyl moieties 
UC21 25.9 210; 270; 333 625 [M+H]+; 647 [M+Na]+ 623 [M-H]- 625.1765 625.1769 C28H32O16 unknown flavone di-C-glycoside similar to Stellarin-2 
40 26.2 210; 270; 343 625 [M+H]+; 647 [M+Na]+ 623 [M-H]- 625.1763 625.1769 Stellarin-2 
UC22 27.0 211; 270; 338 787 [M+H]+; 809 [M+Na]+ 785 [M-H]- 787.2298 787.2298 C34H42O21 unkown flavone triglycoside with two C-linked and one O-linked 
hexosyl moieties 
UC23 31.5 213; 268; 342 625 [M+H]+; 647 [M+Na]+ 623 [M-H]- 625.1759 625.1769 C28H32O16 unknown flavone di-C-glycoside 
41 32.1 211; 268; 348 449 [M+H]+; 471 [M+Na]+ 447 [M-H]- 449.1093 449.1085 Isoorientin 
42 32.6 212; 269; 348 611 [M+H]+; 633 [M+Na]+ 609 [M-H]- 611.1617 611.1613 Isoorientin 3"-O-β-D-glucopyranoside 
43 35.0 207; 249; 301 166 [M+H]+; 148 [M-H2O]
+ 164 [M-H]- 164.0344 164.0347 N-formyl anthranilic acid 
 44 37.1 213; 269; 336 433 [M+H]+; 455 [M+Na]+ 431 [M-H]- 433.1132 433.1135 Isovitexin 
45 37.4 214; 269; 335 595 [M+H]+; 617 [M+Na]+ 593 [M-H]- 595.1659 595.1664 Isovitexin 3"-O-β-D-glucopyranoside 
3 38.8 216; 269; 345 463 [M+H]+; 485 [M+H]+ 461 [M-H]- 463.1237 463.1241 Isoscoparin 
46 39.4 213; 269; 348 625 [M+H]+; 647 [M+Na]+ 623 [M-H]- 625.1763 625.1769 Isoscoparin 3"-O-β-D-glucopyranoside 
47 41.8 215; 274 - 447 [M-H]- 447.0526 447.0531 Glucobrassicin 
UC24 43.5 n.d. - 621 [M-H]- 621.1447 621.1454 C28H30O16 unknown flavonoid with two O-linked hexosyl moieties 
UC25 46.0 295; 321 - 591 [M-H]- 591.1341 591.1349 C27H26O15 unknown flavonoid with two O-linked hexosyl moieties 
UC26 47.8 240; 325 - 621 [M-H]- 621.1444 621.1454 C28H30O16 unknown flavonoid with two O-linked hexosyl moieties 
 
n.d. = not detected; a = found and calculated accurate mass for the respective [M+H]+ or [M-H]- ion; UC1 and UC15 to UC26 are compounds for which only partial structures were 
obtained. 
 
 
 
 
 
 
 
 Table 3. Identified carotenoids from an acetone/hexane (1:1) extract of Isatis tinctoria leaves 
Peak Rt (min) λmax (nm) 
% 
III/IIa 
[M+H]+ 
(m/z) MS/MS Assignment 
UC27 6.2 399, 420, 447 80 601 583, 565, 221 unknown 
48 6.9 399, 419, 446 75 601 583, 565, 221 (Z)-Neochrome 
49 7.5 400, 420, 446 80 601 n.d. (all-E)-Neochrome 
50 8.2 329, 407, 430, 455 10 601 583, 565, 221 (di-Z)-Violaxanthin 
51 8.9 330, 415, 437, 464 40 601 583, 565, 509 (15Z)-Violaxanthin  
52 9.8 330, 415, 437, 464 45 569 551, 533, 476 (13Z)- or (13'Z)-Lutein 
UC28 10.8 382, 401, 425, 444, 471 n.c. 601 n.d. mixture 
32 11.9 420, 443, 470 60 569 551, 533, 459 (all-E)-Lutein 
35 14.4 328, 416, 439, 465 65 569 551, 533, 509 (9Z)-Lutein 
36 17.5 328, 416, 440, 467 60 569 551, 533 (9'Z)-Lutein 
UC29 19.1 327, 418, 442, 467 15 569 551 unknown 
UC30 21.7 336, 405, 428, 451 n.c. 569 551 unknown 
53 23.0 338, 422, 446, 470 10 537 n.d. (15Z)-β-Carotene 
54 30.0 423, 451, 477 25 537 444, 347, 197 (all-E)-β-Carotene 
55 32.3 340, 423, 443, 469 30 537 444, 209, 357 (9Z)-β-Carotene 
 
n.d. = not detected; n.c. = not calculated; a = spectral fine structure obtained according to the method of Lee et al. (2001).  
UC27 to UC30 are carotenoids which could not be unambiguously identified. 
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 Fig.1S. Dichloromethane (A) and methanol (B) extracts of Isatis indigotica were separated by HPLC. 
Application of several detectors as PDA, ELSD, and mass spectrometric systems with electrospray (ESI) 
and atmospheric pressure chemical ionisation (APCI) techniques in positive and negative mode reveal 
the complexity of both extracts. The majority of compounds were identical with compounds observed in 
the closely related species Isatis tinctoria. 
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Fig. 2S. 2D-NMR spectra of compound 64. 
Table 1S. Identified compounds 1-37 in a dichloromethane extract of Isatis indigotica. All compounds were identified on 
the basis of mass spectrometric, high-resolution-mass spectrometric and UV data or by reference compounds. Details 
are available in Table 1.   
 
 
Peak Rt (min) Assignment
UC1 9.0 C21H24N2O2  
UC3 11.0 unknown 
1 12.0 Isatin 
3 12.8 Isoscoparin 
7 13.8 Ferulic acid 
9 19.5 (E)-3-(3’,5’-dimethoxy-4’-hydroxy-benzylidene)-2-indolinone 
10 20.3 Isoindigo 
13 21.3 Tryptanthrin 
UC7 22.0 unknown 
14 23.0 Indigo 
15 24.0 Indirubin 
16 25.8 1-O-β-D-galactopyranosyl-3-O-linolenylglycerol 
18 27.3 α-Lysolecithin 
22 33.6 Linolenic acid 
23 34.5 Ursolic acid 
UC12 34.9 unknown porphyrin derivative 
25 35.4 Linoleic acid 
26 35.6 10-Hydroxy-phaeophorbide 
27 36.4 Phaeophorbide a 
28 37.8 Phaeophorbide a' 
29 38.0 Palmitic acid 
30 38.3 Oleic acid 
31 38.6 Pyrophaeophorbide a 
32 39.7 (all-E)-Lutein 
33 43.3 Stearic acid 
34 43.7 Eicosenoic acid 
35 44.1 (9Z)-Lutein 
36 45.0 (9'Z)-Lutein 
37 52.4 Eicosanoic acid 
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Table 2S. Identified compounds 3, 38-45 in a methanol extract of Isatis indigotica. All compounds were identified on 
the basis of mass spectrometric, high-resolution-mass spectrometric and UV data or by reference compounds. Details 
are available in Table 2.  
 
 
 
Peak Rt 
(min) 
Assignment 
UC16 13.7 C16H16N2O5 unknown anthranilic acid derivative 
UC17 15.9 C20H22N2O 
UC1 17.8 C21H24N2O2 
38 18.7 Indican 
39 23.7 Vicenin-2 
UC20 25.0 C33H40O20 unknown flavones triglycoside with two C-linked and one O-linked 
hexosyl moieties 
40 25.9 Stellarin-2 
UC22 26.8 C34H42O21 unknown flavone triglycoside with two C-linked and one O-linked 
hexosyl moieties 
UC23 31.2 C28H32O16 unknown flavone di-C-glycoside 
41 32.2 Isoorientin 
42 33.5 Isoorientin-O-glucopyranoside 
44 36.3 Isovitexin 
45 36.8 Isovitexin-3"-O-β-D-glucopyranoside 
3 38.3 Isoscoparin 
46 38.8 Isoscoparin-3"-O-β-D-glucopyranoside 
UC24 41.8 C28H30O16 unknown flavonoid with two O-linked hexosyl moieties 
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3.3  Extraction and analysis of intact glucosinolates – A 
validated pressurized liquid extraction / liquid chromato-
graphy - mass spectrometry protocol for Isatis tinctoria, 
and qualitative analysis of other cruciferous plants 
 
  (Mohn et al., J Chromatogr A 2007; 1166:142-151).  
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bstract
Glucosinolates have attracted significant interest due to the chemopreventive properties of some of their transformation products. Numerous
rotocols for the extraction and analysis of glucosinolates have been published, but limited effort has been devoted to optimize and validate crucial
xtraction parameters and sample preparation steps. We carried out a systematic optimization and validation of a quantitative assay for the direct
nalysis of intact glucosinolates in Isatis tinctoria leaves (woad, Brassicaceae). Various parameters such as solvent composition, particle size,
emperature, and number of required extraction steps were optimized using pressurized liquid extraction (PLE). We observed thermal degradation
f glucosinolates at temperatures above 50 ◦C, and loss of >60% within 10 min at 100 ◦C, but no enzymatic degradation in the leaf samples at
mbient temperature. Excellent peak shape and resolution was obtained by reversed-phase chromatography on a Phenomenex Aqua column using
0 mM ammonium formate as ion-pair reagent. Detection was carried out by electrospray ionisation mass spectrometry in the negative ion mode.
nalysis of cruciferous vegetables and spices such as broccoli (Brassica oleracea L. var. italica), garden cress (Lepidium sativum L.) and black
ustard (Sinapis nigra L.) demonstrated the general applicability of the method.
2007 Elsevier B.V. All rights reserved.
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. Introduction
Glucosinolates are a class of nitrogen and sulfur contain-
ng secondary metabolites which are characteristic of the plant
rder of Capparales. More than 120 glucosinolates have been
escribed so far, mostly from the family Brassicaceae [1]. The
tructure of glucosinolates consists of a -d-glucopyranosyl
oiety linked via a sulfur atom to an N-hydroximinosulfate
ster, and of a modified amino acid side chain. The highly
ariable structure of the side chain includes aliphatic (straight
hain, branched chain, hydroxylated, sulfur containing, keto-
erivatives), alkenylic, aromatic, hydroxyalkyl benzoated or
ndolic moieties and can be multiply glycosylated. Glucosi-
∗ Corresponding author. Tel.: +41 61 267 14 25; fax: +41 61 267 14 74.
E-mail address: matthias.hamburger@unibas.ch (M. Hamburger).
c
a
t
s
h
b
021-9673/$ – see front matter © 2007 Elsevier B.V. All rights reserved.
oi:10.1016/j.chroma.2007.08.028
118n (PLE); Accelerated solvent extraction (ASE); Quantitative analysis; Quanti-
olates are found in all plant parts, but occurrence and
oncentration vary according to species, environmental fac-
ors, age or type of tissue [2]. Following tissue damage,
hese nonvolatile precursors undergo enzymatic hydrolysis by
thioglucohydrolase (E.C. 3.2.1.147, myrosinase) to glucose
nd a variety of degradation products (isothiocyanates, nitriles,
hiocyanates, epithiocyanates, epithionitriles and oxazolidines),
hich are responsible for the hot, pungent taste and most bio-
ogical activities of glucosinolates [3].
Intact glucosinolates and their breakdown products possess
hemoecological functions and serve not only as defense mech-
nisms against herbivores and pathogens, but also as attractant
o specialized toxin tolerant insects [4–6].Glucosinolates occur in numerous vegetables and spices
uch as cabbage, broccoli, cauliflower, cress, mustard, and
orseradish. Interest in the role of dietary glucosinolates has
een stimulated by the observation of cancer chemopreventive
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roperties of certain breakdown products, such as sulforaphane
erived from glucoraphanin (4-methylsulfinyl butyl glucosino-
ate) found in broccoli. Sulforaphane and other isothiocyanates
revent tumor growth in animal models by blocking cell cycle
rogression and promotion of apoptosis [2,4,7,8].
Given the importance of glucosinolates, numerous methods
or extraction and analysis of these compounds have been pub-
ished. In addition, official protocols have been issued, e.g. for
uantitative analysis of glucosinolates in vegetable and spices
9]. Typically, extraction is carried out in water [10–12] or
mixture of methanol and water [13–15]. To prevent enzy-
atic degradation by myrosinase, the material to be extracted is
rst treated at 100 ◦C [16–19]. Others have performed extrac-
ion at elevated temperature, typically 70–100 ◦C, to inactivate
yrosinase [10–15]. However, these conditions have not been
ptimized or validated.
The majority of methods analyze glucosinolates by reversed-
hase HPLC of their desulfo-derivatives. In these cases, the
xtracted glucosinolates are adsorbed onto a solid support, typ-
cally Sephadex A-25, followed by enzymatic desulfation and
lution of the desulfoglucosinolates [9,20]. More recently, meth-
ds for direct separation of intact glucosinolates have been
roposed to circumvent this tedious sample preparation. Here,
on-pairing reagents such as tetraalkyl ammonium bromide
21,22], trifluoroacetic acid [16,18,23,24], ammonium acetate
25] or triethylamine/formic acid buffers [26] have been used
n conjunction with reversed-phase chromatography on RP-18
olumns. However, peaks usually suffered from inacceptable
ailing, and separation was usually not optimal. The general
roblem with published protocols for extraction and analysis of
lucosinolates was that, in most cases, insufficient information
s available concerning method validation.
Due to the fact that specific biological effects of different glu-
osinolates vary considerably, it is critical to develop sensitive
nd reliable methods for efficient identification and quantifica-
ion of the particular glucosinolate under investigation. We here
eport on the optimization and validation of a method for extrac-
ion and direct analysis of glucosinolates, and we demonstrate
he applicability of the assay with the analysis of woad (Isatis
inctoria and I. indigotica), a dye and medicinal plant with a
ong history in Europe and in Traditional Chinese Medicine. The
eneral applicability of the HPLC conditions for the analysis of
ntact glucosinolates is explored with a number of glucosinolate-
ontaining dietary plants and spices such as broccoli (Brassica
leracea L. var. italica), garden cress (Lepidium sativum L.) and
lack mustard (Sinapis nigra L.).
. Experimental
.1. Plant material
Leaf material of woad was harvested in August 2003 from
rst year plants (rosette stage) of defined I. tinctoriaL. selections
Jenaer Waid”, and “Kieler Waid” and Isatis indigotica Fort.
ultures, which were grown on experimental plots of the Agricul-
ural Research Station of Thuringia (TLL), Dornburg, Germany.
eeds from I. tinctoria were also obtained from TLL, Dornburg.
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Broccoli heads (B. oleracea L. var. italica) and garden cress
L. sativum L.) were purchased on the local market in Basel,
witzerland. Black mustard seeds (Brassica nigra L.) were pur-
hased from Ha¨nseler AG, Herisau, Switzerland.
Fresh Isatis leaf material was shock frozen with liquid nitro-
en immediately after harvest. Prior to extraction, the leaves
ere lyophilized, powdered with a ZM 1 ultracentrifugal mill
Retsch, Haan, Germany) and kept frozen at below −20 ◦C until
xtraction. Broccoli and garden cress were treated the same way,
lack mustard seeds were shock frozen and cryomilled before
xtraction.
.2. Chemicals
Analytical grade solvents for extraction and HPLC grade
olvents for chromatography were purchased from Scharlau
Barcelona, Spain). HPLC grade water was obtained by an
ASY-pure II (Barnstead; Dubuque IA, USA) water purifi-
ation system. Ammonium formate (≥99.995%), formic acid
98.0–100%), sinigrin (2) (2-propenyl glucosinolate) (≥99%)
nd 1,3,5-trimethoxybenzene (≥99%) were purchased from
igma–Aldrich (Buchs, Switzerland).
Potassium salts of progoitrin (3) (2(R)-2-hydroxy-3-butenyl
lucosinolate), epiprogoitrin (1) (2(S)-2-hydroxy-3-butenyl glu-
osinolate), gluconapin (4) (3-butenyl glucosinolate) and
lucotropaeolin (7) (phenylmethyl glucosinolate) were pur-
hased from the Department of Natural Sciences, University
f Copenhagen, Denmark.
.3. Isolation of glucosinolates
Glucobrassicin (8) (3-indolylmethyl glucosinolate), sul-
oglucobrassicin (5) (1-sulfo-3-indolylmethyl glucosinolate), 4-
ydroxyglucobrassicin (6) (4-hydroxy-3-indolylmethyl glucosi-
olate) and neoglucobrassicin (9) (N-methoxy-3-indolylmethyl
lucosinolate) were isolated from seeds of I. tinctoria (“Kieler
aid”).
Isatis seeds (21.6 g) were defatted by Soxhlet-extraction for
h with 400 mL petrolether (boiling range 40–60 ◦C). After
vaporation to dryness, the residue was extracted three times
ith water (room temperature, 3 × 150 mL), centrifuged (5 min,
600 × g, room temperature) and filtered (standard laboratory
aper filter, 7–12m pore size, Schleicher & Schuell, Feld-
ach, Switzerland). The aqueous solutions were concentrated
o 45 mL in vacuo, and 5 mL acetonitrile were added. After cen-
rifugation, the supernatant was introduced into a column packed
ith DEAE-Sephadex A-25 (50 g). The column was eluted with
ater/acetonitrile 80:20 until the eluate was colorless. Glucosi-
olates were eluted with a mixture of 0.1 M K2SO4/acetonitrile
0:20 at 3.2 mL/min and monitored with UV detection (Phar-
acia Uvicord S II) at 229 nm. Fractions were analyzed by
PLC–MS and appropriate fractions combined and evaporated
o dryness. For desalting, isolated sulfoglucobrassicin (5) was
issolved in aqua dest., applied on a Sephadex G10 column
Sephadex G10, particle size 40–120m in water and filled in
column of 2.5 cm diameter) and eluted with water. Finally,
solated glucosinolates were freeze dried. Purity and structures
1 atogr. A 1166 (2007) 142–151
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Fig. 1. Optimization of extraction parameters: influence of the extraction tem-
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f isolated compounds were confirmed by NMR and LC–MS
xperiments.
.4. Quantitative NMR (qHNMR) for purity assessment of
eference compounds
The purity of reference glucosinolates was determined by
uantitative NMR with 1,3,5-trimethoxybenzene as internal
tandard. All NMR spectra were recorded at 303 K on a Bruker
RX500 NMR spectrometer equipped with a 5 mm SEI probe
ith radio-frequency coils optimized for the detection of 1H.
The longitudinal relaxation constant, T1, was measured to
etermine the recycle delay needed for the magnetization to
eturn to equilibrium. This was achieved with the pulse sequence
t1ir” from Bruker. Trimethoxybenzene was measured with 40
qually spaced inversion recovery delays between 0.25 and
0.0 s. Following four dummy scans, eight scans were recorded
or each inversion recovery delay with a recycle delay of 100 s
etween successive scans. The T1 value of the trimethoxy hydro-
ens in trimethoxybenzene was measured to be 2.4 s.
To determine the concentration of the glucosinolates, the data
as recorded using the pulse sequence “zgpr” from Bruker. The
arrier frequency was set to the resonance frequency of the resid-
al HOD solvent signal at 4.705 ppm. The presaturation pulse
onsisted of a rectangular pulse applied for 1 s at an intensity
f 24 Hz. A spectral width of 20 ppm was monitored with 64k
oints, implying an FID resolution of 0.16 Hz per point. For each
ample, following two dummy scans, 16 scans were recorded.
o ensure the full recovery of the magnetization following each
0◦ pulse, a recycle delay of 20 s, a value longer than five times
he T1 of any signal used to quantify the concentration.
Trimethoxybenzene (1.0 mg; Mettler Toledo AT 20 microbal-
nce, reproducibility: 4g) was dissolved in 1.8 mL methanol-
4 (adjusted to give a concentration of 3.333 mM). This solution
as diluted by a factor of 10 with D2O. Glucosinolates were sep-
rately weighed into NMR tubes (1.0 mg) and dissolved with the
iluted trimethoxybenzene solution to give an exact concentra-
ion of 3 mM glucosinolate. Data were processed and analyzed
sing XWIN-NMR version 3.6 running on a Linux PC. Each data
ize for each experiment was doubled by zero-filling in the time
omain. The FID was then multiplied by an exponential decay
podization function of 0.3 Hz prior to Fourier transformation.
o determine the concentration of compounds 5–9, the aromatic
egion of the spectrum between 7 and 8 ppm was integrated and
ivided by the appropriate number of hydrogens from which
t originated. The concentration of glucosinolates 1–4, which
o not contain aromatic hydrogens, was determined by integra-
ion of the anomeric hydrogen at 4.5 ppm. The obtained values
ere compared to that of the integrated trimethoxy signal from
rimethoxybenzene whereas nine protons of trimethoxybenzene
0.333 mM) corresponded to one proton glucosinolate (3 mM).
.5. Pressurized liquid extraction (PLE) of plant samplesPressurized liquid extraction was carried out with an ASE 200
nstrument (Dionex; Sunnyvale, CA, USA) with attached solvent
ontroller. Extraction of 1.0 g frozen, powdered plant material
H
r
c
120erature on the yield of glucosinolates 5 and 8 from Isatis tinctoria leaves
“Jenaer Waid”) obtained with 70% MeOH and three extraction cycles. The
ields obtained at 50 ◦C were set as 100%.
as carried out in 11 mL steel cartridges. Standard conditions
or all extractions were as follows: preheat time: 1 min; static
xtraction per cycle: 5 min; flush: 100 % of cell volume; purge:
0 s with nitrogen; pressure: 120 bar.
Solvent composition (Supplementary Material, Fig. 1), tem-
erature (40–100 ◦C) (Fig. 1), number of required extraction
teps (Fig. 2) and particle size (sieve size 0.5, 0.75 and 1.0 mm)
Supplementary Material, Fig. 2) were optimized by repeated
xtractions and changing the parameter of choice. Final con-
itions were: particle size 0.5 mm, 50 ◦C, 70 % methanol in
ater, three extraction cycles of 5 min. Possible degradation of
lucosinolates by myrosinase activity was analyzed by extrac-
ion of freshly thawed leaf material at defined time points of 0,
0, 100 and 200 min after filling the cartridge (Supplementary
aterial, Fig. 3).
.6. LC–MS instrumentation and conditions
HPLC separations were carried out on an Agilent series 1100
ystem equipped with degasser, binary high pressure mixing
ump, column thermostat and photodiode array (PDA) detec-
or (Agilent Technologies; Waldbronn, Germany). A liquid
andler 215 (Gilson; Mettmenstetten, Switzerland) was used
s autosampler. The HPLC was coupled to an Esquire 3000
lus ion trap mass spectrometer equipped with an electrospray
ESI) interface (Bruker Daltonics; Bremen, Germany). High-
esolution mass spectra were obtained on a micrOTOF ESI-MS
ystem (Bruker Daltonics) connected to an Agilent 1100 series
PLC. Data acquisition and processing was performed using
yStar 3.0 software (Bruker Daltonics).
Negative ion LC–MS spectra on the ion trap instrument were
ecorded after optimization of settings, under ion charge control
onditions (ICC 30000) at a scan speed of 13000 m/z/s, using a
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was measured as five replicates. Calibration curves are shown
in Supplementary Material, Table 2.
The dried extracts, obtained by extraction of 1.0 g frozen,
powdered plant material, were dissolved in 100.0 mL IS solu-
Table 1
Limits of detection (LOD) and quantification (LOQ) for glucosinolates 1–9
Compound LOD LOQ
Epiprogoitrin (1) 1 3
Sinigrin (2) 1 3
Progoitrin (3) 1 3
Gluconapin (4) 0.5 1
Sulfoglucobrassicin (5) 4 12
4-Hydroxyglucobrassicin (6) 2 5ig. 2. Influence of the extraction temperature on yields of glucosinolates 5 and
in successive PLE extraction cycles. Plant material was identical with that used
n Fig. 1. The cumulative yields of four extraction cycles were set as 100%.
auss filter width of 0.2 m/z. Nitrogen was used as a drying gas
t a flow rate of 10 L/min and as a nebulizing gas at a pressure
f 30 psi. The nebulizer temperature was set at 300 ◦C. Spectra
ere recorded between 0 min and 25 min in the range of m/z
00–800. Capillary voltage was at 4500 V, endplate offset at
500 V, capillary end voltage at −115.0 V, skimmer voltage
40.0 V and trap drive at 53.4.
Conditions for LC–TOF MS were as follows: spectra were
ecorded in the range of m/z 100–600 in negative mode. Nitro-
en was used as a nebulizing gas at a pressure of 2.0 bar and
s a drying gas at a flow rate of 9.0 L/min (dry gas tempera-
ure 240 ◦C). Capillary voltage was at 4500 V, endplate offset at
500 V, hexapole at 250.0 Vpp, skimmer 1 at −50 V and skim-
er 2 at −22.5 V. Instrument calibration was performed using a
eference solution of sodium formate 0.1% in isopropanol/water
1:1) containing 5 mM sodium hydroxide. Typical mass accu-
acy was ±1 ppm.
G
G
N
A
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.7. HPLC–MS method development and validation
RP-18 columns from different manufacturers, including
tlantis and Sunfire (Waters; Milford, MA, USA), Luna and
qua (Phenomenex; Aschaffenburg, Germany)], OmniPac pax
00 (Dionex; Sunnyvale, CA, USA) and LiChrospher 60 rp-
elect b (Merck; Darmstadt, Germany) columns, were tested for
uitability in glucosinolate analysis. Finally separations were
arried out on an Aqua C18 125 A˚ column (5m, 250 × 4.6 mm
.D.; Phenomenex) equipped with a guard column (4.0 × 3.0 mm
.D.). Mobile Phase A consisted of a solution of 10 mM aqueous
mmonium formate, adjusted to pH 6.4 with formic acid, and
obile phase B was acetonitrile. A linear gradient starting at 1%
to 3% B (7 min), 3% B to 15% B (5 min), 15% B to 30% B
13 min) was shown to give best separation of all compounds to
e analyzed. Flow rate was 1.0 mL/min. A split ratio of 1:4 was
sed with the ESI interface. Column temperature was 20.0 ◦C.
he sample injection volume was 20L.
Reproducibility was assessed in five replicates with a stan-
ard solution of all glucosinolates at a concentration of 1g/mL
nd the relative standard deviation was calculated. Intra-day and
nter-day repeatability was verified in the course of the analy-
is. Limit of detection (S/N ratio of 3) and limit of quantification
S/N ratio of 10) were determined by serial dilution of a standard
olution containing all glucosinolates (Table 1). Accuracy was
etermined for the major compounds sulfoglucobrassicin and
lucobrassicin, and the minor compound progoitrin. An extract
f “Jenaer Waid” was spiked with defined amounts, whereby the
mounts added were comparable to those of compounds origi-
ally present in the extract. Amounts added and recovery rates
re listed in Supplementary Material, Table 1.
.8. Quantitative analysis
A solution of 10 mM ammonium formate containing sini-
rin (2 mg/L) as internal standard (IS solution) was used for all
ilution steps. Stock solutions (1 mg/mL) of all reference com-
ounds were prepared in IS solution, serial dilutions covered a
oncentration range of 20–0.1g/mL. Each standard solutionlucotropaeolin (7) 0.2 0.5
lucobrassicin (8) 1 3
eoglucobrassicin (9) 1 3
mount of compound injected (ng).
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ion. Dilutions of 1:10 and 1:100 were prepared with IS solution.
ll solutions were centrifuged (5 min, 1600 × g, 4 ◦C) prior to
PLC analysis. Measurements were done in triplicate.
. Results
.1. Isolation of reference compounds and control of purity
Most glucosinolates used in this study (Fig. 3) were not
ommercially available and had to be isolated as reference
ompounds (see Section 2). LC–MS analysis of isolated com-
ounds showed a purity of higher than 99 %. Structures were
lso confirmed by NMR. The spectra did not show any addi-
ional signals of organic impurities. Given that the glucosinolates
sed as reference compounds are present as potassium salts and
ay contain an unknown amount of water of crystallization,
e determined the absolute content with the aid of quantita-
ive 1H NMR (qHNMR). The purity was >99% for sinigrin
2) (calculated as C10H17NO9S2), 87% for epiprogoitrin (1) (as
11H19NO10S2), 90% for progoitrin (3) (as C11H19NO10S2),
1% for gluconapin (4) (as C11H19NO9S2) and >99% for
lucotropaeolin (7) (as C14H19NO9S2), and 70% for gluco-
rassicin (8) (as C16H20N2O9S2), 61% for neoglucobrassicin
Fig. 3. Structures of glucosinolates 1–9.
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9) (as C17H22N2O10S2), 19% for sulfoglucobrassicin (5) (as
16H20N2O12S3) and 17% for 4-hydroxyglucobrassicin (6) (as
16H20N2O10S2).
.2. Development and validation of LC–MS conditions
LC–MS analysis of intact glucosinolates requires the use of
on-pair reagents to neutralize the negative charge of the sulfate
roups. Preliminary tests with trifluoracetic acid (TFA; 0.05%,
.1% and 0.5%) resulted in inacceptable peak tailing and sep-
ration, especially for sulfoglucobrassicin which contains two
ulfate groups. Non-volatile ion-pair reagents such as tetraalkyl
mmonium bromides could not be used because of MS detec-
ion. However, symmetrical peak shapes and good separation
ere also obtained with ammonium formate which was then
sed for all further separations.
We initially tested a range of RP-18 columns in conjunction
ith TFA and ammonium formate buffer in several concen-
rations. Best results were obtained on a Phenomenex Aqua
olumn which was used for all subsequent experiments. The
nfluence of the concentration of ammonium formate buffer (1,
, 10 and 20 mM) on peak shape and resolution was inves-
igated. Best results were obtained with 10 mM ammonium
ormate. In a range between 5 mM and 20 mM only minor
hifts in retention time (<0.2 min) were observed, without
hange in peak shape, but a severe decline in peak symme-
ry and resolution occurred with a 1 mM buffer concentration.
or further optimization of chromatographic separation, we
nvestigated the influence of column temperature (15.0 ◦C,
0.0 ◦C, 25.0 ◦C and 30.0 ◦C). Best resolution and peak shape
as observed at 20.0 ◦C, in particular for compounds 1–3.
t 30.0 ◦C, peaks 1–3 could not be resolved. The solvent
sed for dissolution of samples proved to be critical. Injecting
ethanolic or 70% aqueous-methanolic solutions of reference
ompounds and extracts resulted in peak tailing, but sym-
etrical and sharp peaks were obtained when samples were
issolved in mobile phase A. The HPLC–MS analysis of a stan-
ard mixture of 1–9 under optimized conditions is shown in
ig. 4.
For quantitative analysis, extracted ion traces corresponding
o [M− H]− quasimolecular ions were used for signal integra-
ion, with exception of sulfoglucobrassicin (5). Here, the highest
ignal (m/z 447) in the spectrum, corresponding to the loss of
sulfate moiety, was used. Sinigrin (2), a glucosinolate which
s not present in the genus Isatis, was used as internal standard
or quantitative analysis of woad (I. tinctoria and I. indigotica)
amples. Calibration curves (Supplementary Material, Table 2)
ere found to be quadratic functions for mass spectrometric
etection (R2 ≥ 0.9998). Reproducibility was satisfactory (RSD
.0–2.5%; n = 5). Inter-day repeatability over time of analysis
or 1–9 was between 96.5% and 101.0% after 67 h. Limit of
etection (S/N ratio of 3) and limit of quantification (S/N ratio
f 10) were determined by serial dilution of a standard solution
f all glucosinolates (Table 1).
Accuracy of the method was determined with spiking
xperiments. Recovery rates for the major compounds sulfoglu-
obrassicin (5) (98%) and glucobrassicin (8) (97%), as well
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cig. 4. HPLC separation of a mixture of reference compounds 1–9. Sinigrin (2)
elow are the extracted ion chromatogram (EIC) obtained by ESI-MS in the ne
s for progoitrin (3) (102%) were obtained (Supplementary
aterial, Table 1).
.3. Optimization and validation of the extraction protocolThe optimized LC–MS conditions were then employed for
he optimization and validation of an extraction protocol with
satis samples. We decided upon pressurized liquid extraction
p
e
w
123d as internal standard (IS). The chromatogram on top was recorded at 229 nm;
ion mode, and the mass spectra of the individual compounds.
PLE) as an extraction technique, given the numerous advan-
ages over other methods of plant extraction and our own
xperience with the method [27–30]. We selected the major glu-
osinolates5 and8 as markers for the optimization and validation
rocedure.
In a preliminary experiment, solvent compositions and
xtraction temperatures typically used in published methods
ere compared. The results showed that a combination of aque-
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Fig. 5. Glucosinolates in Isatis leaf extracts. Base peak chromatograms (BPC)
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us MeOH (70%) and moderately elevated temperatures were
ikely to give the highest yields (Supplementary Material, Fig.
). In the next step, we investigated the influence of extraction
emperature on the yield of 5 and 8 in more detail. As shown
n Fig. 1, thermal degradation of glucosinolates was observed at
emperatures above 50 ◦C. A loss of >60% was found at 100 ◦C
hen using three extraction cycles of 5 min each. The total yield
f glucobrassicin (8) and sulfoglucobrassicin (5) at 40 ◦C was
lmost as high as at 50 ◦C. Analysis of the yield of the succes-
ive extraction cycles (Fig. 2), showed that extraction efficiency
as clearly better at 50 ◦C. Cumulative yields of 99.4% and
9.7% were achieved for 5 and 8 with three extraction cycles
f 5 min, whereas only 97.7% and 97.8 % were obtained at
0 ◦C. An extraction temperature of 50 ◦C and three extraction
ycles of 5 min each were used for all subsequent experiments.
e also investigated the influence of particle size of the herbal
aterial on the yields of extracted glucosinolates. Isatis leaves
ere cryomilled in an ultracentrifugal mill, using sieve sizes
f 1.0, 0.75 and 0.5 mm. Differences observed in cumulative
ields were small. With a sieve size of 1 mm, 98.5% of sul-
oglucobrassicin (5) were extracted after 3 extraction cycles,
ompared to 99.5% with sieve sizes 0.75 and 0.5 mm. For glu-
obrassicin (8), the yields were 98.9% for sieve size of 1.0 mm,
nd 99.7% for 0.75 and 0.5 mm. (Supplementary Material,
ig. 2).
The enzyme thioglucohydrolase (E.C. 3.2.1.147, myrosi-
ase), is responsible for the hydrolysis of glucosinolates to
lucose and a variety of breakdown products, which are respon-
ible for the hot and pungent taste of many cruciferous vegetable
nd spices. Myrosinase is known to be quite stable in dried
lant material at room temperature and can be reactivated upon
ddition of water, e.g. during extraction. To determine whether
yrosinase activity in thawed Isatis leaf material possibly con-
ounded the yields of glucosinolates in extractions with our PLE
rotocol, we carried out an experiment in which PLE cartridges
lled with identical Isatis leaf samples were extracted at defined
imes after thawing. The sample extracted immediately (0 min)
erved as reference (100%). No measurable decrease of sulfoglu-
obrassicin (5) and glucobrassicin (8) was seen in cartridges
hich were kept at ambient temperature up to 200 min after
he start of the experiment (Supplementary Material, Fig. 3).
e concluded that myrosinase activity was negligible in our
ssay conditions and that, consequently, larger sample series
ould be prepared for extraction without undue risk of loss in
nalytes.
.4. Quantitative analysis of woad extracts
The optimized and validated method for sample preparation
nd LC–MS analysis was used to determine the content in glu-
osinolates 1, and 3–9 in three different woad samples. PLE
xtracts of two defined cultures of I. tinctoria (“Jenaer Waid”
nd “Kieler Waid”) and of the taxiconomically closely related
satis indigoticawere prepared. The two Isatis species are indigo
yes and medicinal plants with important anti-inflammatory and
nti-allergic properties [31–34]. Fig. 5 shows the base peak
hromatogram (BPC) of the extract and the extracted ion chro-
I
a
h
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124nd extracted ion chromatograms (EIC) of major glucosinolates are shown for
wo Isatis tinctoria accessions (“Jenaer Waid” and “Kieler Waid”), and for I.
ndigotica. Sinigrin (2) is used as internal standard (IS).
atograms (EIC) used for peak integration of the identified
lucosinolates.
Due to large differences in concentration of glucosinolates,
t was necessary to analyze the extracts in different dilutions
or quantification. In particular, high dilutions (1:100) of I. tinc-
oria extracts were prepared to determine sulfoglucobrassicin
5) and glucobrassicin (8), while progoitrin (3) and hydrox-
glucobrassicin (6) were measured in a 1:10 extract dilution
f I. indigotica. The remaining glucosinolates were quantified
n undiluted extracts (Table 2).
The glucosinolate spectra of both Isatis species varied
emarkably. In comparison, the extract of I. indigotica did not
ontain sulfoglucobrassicin (5) or glucobrassicin (8) which are
he major glucosinolates of I. tinctoria. Progoitrin (3) and 4-
ydroxyglucobrassicin (6) were the main glucosinolates in the
. indigotica extract. The aromatic glucotropaeolin (7) as well
s other indole-type glucosinolates such as glucoisatisin and
ydroxyglucoisatisin which have been reported from I. tinctoria
. seeds could not be found in the Isatis leaf samples.
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Table 2
Glucosinolate content (in mol/g dry weight) in woad extracts
Compound I. indigotica I. tinctoria (Kiel) I. tinctoria (Jena)
Epiprogoitrin (1) 0.16 ± 0.01a 0.10 ± 0.01a 0.16 ± 0.01a
Progoitrin (3) 2.54 ± 0.03b 0.15 ± 0.01a 0.20 ± 0.01a
Gluconapin (4) n.d. 0.03 ± 0.01a n.d.
Sulfoglucobrassicin (5) n.d. 11.38 ± 0.37c 13.51 ± 0.23c
4-Hydroxyglucobrassicin (6) 0.43 ± 0.01b n.d. 0.04 ± 0.01a
Glucotropaeolin (7) n.d. n.d. n.d.
Glucobrassicin (8) n.d. 6.14 ± 0.12c 14.29 ± 0.25c
Neoglucobrassicin (9) n.d. 0.19 ± 0.01a 0.16 ± 0.01a
All measurements were in triplicate.; n.d.: not detected.
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ia Undiluted extract.
b Dilution 1:10.
c Dilution 1:100.
.5. Qualitative analysis of glucosinolates in cruciferous
egetables and spices
Cruciferous vegetables and spices such as broccoli, garden
ress and black mustard were analyzed to demonstrate the gen-
ral applicability of the method. LC–TOFMS in negative mode
as used to confirm the molecular formula of glucosinolates.
ig. 6 shows extracted ion chromatograms of glucosinolates
dentified in broccoli extracts. Besides minor glucosinolates,
lucoerucin (C12H23NO9S3, calc. 421.0535; found: 421.0535),
ig. 6. Major glucosinolates identified in broccoli. Base peak chromatogram
BPC) of the extract (top) and extracted ion chromatograms (EIC) of major
lucosinolates are shown.
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125lucoraphanin (C12H23NO10S3, calc.: 437.0484; found:
37.0483), glucobrassicin (8) (C16H20N2O9S2, calc.: 448.0610;
ound 448.0608), 4-methoxyglucobrassicin (C17H22N2O10S2,
alc.: 478.0716 found: 478.0719) and neoglucobrassicin (9)
C17H22N2O10S2, calc.: 478.0716 found: 478.0715) could be
dentified.
Glucotropaeolin (7) (C14H19NO9S2, calc.: 409.0501;
ound 409.0503) eluted at 16.2 min was the major glucosi-
olate in garden cress, followed by 4-methoxyglucobrassicin
C17H22N2O10S2, calc.: 478.0716; found 478.0715) at
9.9 min as a minor compound (Fig. 7). Black mustard
eeds contained sinigrin (2) (C10H17NO9S2, calc.: 359.0345;
ound 359.0346) as the dominant compound, and gluconapin
4) (C11H19NO9S2, calc.: 373.0501; found 373.0498), glu-
oibervirin (C11H21NO9S3, calc.: 407.0378; found 407.0376),
luconasturtiin (C15H21NO9S2, calc.: 423.0658; found
23.0656) and 4-hydroxyglucobrassicin (6) (C16H20N2O10S2,
alc.: 464.0559; found 464.0557) as minor glucosinolates
Fig. 8).
ig. 7. Major glucosinolates identified in garden cress. Base peak chromatogram
BPC) of the extract (top) and extracted ion chromatograms (EIC) of major
lucosinolates are shown.
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Fig. 8. Major glucosinolates identified in black mustard seeds. Base peak chro-
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LC–MS performance was sufficiently stable over extended peri-atogram (BPC) of the extract (top) and extracted ion chromatograms (EIC) of
ajor glucosinolates are shown.
. Discussion
In 1982, Minchinton et al. [20] published a desulfatation pro-
edure for the quantification of glucosinolates, which served as
he basis for the official method of the European Community [9],
nd for the majority of publications reporting quantitative data
n glucosinolates. Comparatively few publications have recently
ttempted a direct analysis of glucosinolates, and limited infor-
ation is available concerning validation of extraction, sample
orkup and chromatographic analysis.
For natural product analysis, purity assessment of reference
ompounds is often incomplete or even lacking. This is also
he case for glucosinolates [10,15,24]. Due to their ionic nature,
ssessment of the true content is particularly critical, as ref-
rence samples may contain unknown amounts of salts and
ater of crystallization. Quantitative 1H NMR (qHNMR) is
he currently most appropriate method to determine the abso-
ute amount of compound in a reference sample, and has been
uccessfully applied in natural product analysis [35,36]. Using
,3,5-trimethoxybenzene as reference, we determined the con-
o
o
e
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ent of all purchased and isolated glucosinolates references. For
ompounds 1–9, previous analysis by HPLC and by qualitative
MR gave >99% purity. However, qHNMR data revealed signif-
cant differences of true content, ranging from >99% for sinigrin
2) to 17% for 4-hydroxyglucobrassicin (6). The majority of
eferences were in the range of 60–90% purity.
The result of any quantitative assay of a herbal drug critically
epends on the extraction step which precedes the dosage. In
ll published methods for glucosinolate analysis, limited effort
as devoted to optimization and validation of crucial extrac-
ion parameters and sample preparation steps. In our study, we
sed pressurized liquid extraction (PLE), a technique that is well
uited for plant extraction [30,37]. Based on own experience
n development of validated PLE procedures [27–29,38–40],
e optimized critical parameters such as solvent composi-
ion, particle size of herbal drug, temperature, and number of
equired extraction steps. An unexpected finding was the extent
f thermal degradation at temperature above 50 ◦C. This obser-
ation revealed a problem with existing methods [9–15], where
xtractions were typically carried out at temperatures between
0 ◦C and 100 ◦C to inactivate myrosinase, even though ther-
al degradation of glucosinolates during cooking of vegetables
as been reported [3,41,42]. Compared to other classes of plant
etabolites, glucosinolates appeared particularly sensitive to
eat. Temperatures of 60–70 ◦C have been, typically used in
alidated PLE methods for various classes of natural products
27–29,38] including labile compounds such as the indigo pre-
ursors isatan A and B in woad [39], and temperatures as high
s 120 ◦C were optimal for the extraction of triterpenoidal esters
n evening primrose seeds [40].
Enzymatic hydrolysis of glucosinolates by myrosinase has
een considered a critical issue in extraction, and published
uantitative assays therefore aimed at inactivating the enzyme,
y using denaturing solvents [13–15,25,26] or extraction at ele-
ated temperatures [9–15,20,22]. We investigated possible loss
f 5 and 8 due to myrosinase. In I. tinctoria leaves which
ad been freeze-dried, stored at −20 ◦C and thawed prior to
xtraction, we found no enzymatic degradation over 200 min at
mbient temperature (Supplementary Material, Fig. 3). These
ata, however, cannot be extrapolated to fresh plant material,
here myrosinase activity is expected due to the high water
ontent.
Chromatography of intact glucosinolates requires suitable
dditives in the mobile phase. Trifluoracetic acid has been used
n earlier studies [16,18,23] but did not result in acceptable
eak shape and chromatographic resolution in our preliminary
ests. Better results were obtained with ammonium formate, but
xtensive testing of several stationary phases from different man-
facturers revealed major differences in performance. Sample
reparation for HPLC analysis turned out to be critical. Removal
f the extraction solvent (70% methanol) and redissolving in
obile phase A substantially improved peak shape.
Thanks to the use of the internal standard sinigrin (2), theds. Inter-day repeatability was in the range of 96.5% to 101.0%
ver 67 h. Accuracy was satisfactory, as determined by spiking
xperiments with the major glucosinolates sulfoglucobrassicin
atogr.
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5) (98%) and glucobrassicin (8) (97%), and with the minor com-
ound progoitrin (3) (102%) (Supplementary Material, Table
). Limited information is available concerning method val-
dation of published procedures. Song et al. [18] and Tian
t al. [24] determined validation parameters such as limit of
etection, accuracy and intra-assay precision with intact glucosi-
olates. Reported LODs (0.4–0.6 pmol [24]) were comparable to
ur findings. However, analyte recoveries determined by spik-
ng experiments were lower (≥85%) than in our experiments
≥97%).
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Figure 1: Optimization of extraction parameters. Influence of the solvent composition on the 
yield of glucosinolates 5 and 8 from Isatis tinctoria leaves (“Jenaer Waid”). The yields 
obtained at 60°C with 70% MeOH were set as 100%. 
 
 
Figure 2: Optimization of extraction parameters. Influence of the particle size on the yield 
of glucosinolates 5 and 8 extracted from Isatis tinctoria leaves (“Jenaer Waid”). The 
cumulative yields of four extraction cycles were set as 100%. 
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Table 1: Recovery rates for compounds 3, 5 and 8. 
 
 
Compound 
Amount added  
to extract 
Recovered 
amount* 
Relative recovery 
rates 
Progoitrin (3) 10.0 10.2 ± 0.6 102% 
Sulfoglucobrassicin (5) 70.0 68.5 ± 0.3 98% 
Glucobrassicin (8) 20.0 19.4 ± 0.3 97% 
 
*Amounts in ng on column (20μl injection). Determinations were made in triplicate.  
 
 
 
 
 
Table 2: Calibration curves for compounds 1, and 3-9 
 
 
Compound Curve Concentration* [mg/ml], R2 
Epiprogoitrin (1) y = 85.907x2 - 3115.1x + 71372 0.0001 - 0.02; R2 = 0.9999 
Progoitrin (3) y = 97.22x2 - 3818.4x + 88592 0.0002 - 0.02; R2 = 0.9999 
Gluconapin (4) y = 192.58x2 + 1023.1x + 28740 0.0001 - 0.02; R2 = 1 
Sulfoglucobrassicin (5) y = 7.7837x2 + 596.33x - 7186.8 0.001 - 0.02; R2 = 0.9999 
4-Hydroxyglucobrassicin (6) y = 18.002x2 - 34.08x + 14458 0.0005 - 0.02; R2 = 1 
Glucotropaeolin (7) y = 189.91x2 + 9274.3x - 58217 0.0001 - 0.02; R2 = 0.9998 
Glucobrassicin (8) y = 48.575x2 - 1221.7x + 46037 0.0002 - 0.02; R2 = 0.9999 
Neoglucobrassicin (9) y = 69.715x2 + 856.11x + 27276 0.0002 - 0.02; R2 = 1 
 
* Concentration range for which the curves apply. Solutions were analyzed in five replicates. 
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3.4  Seasonal changes and effect of harvest on 
glucosinolates in Isatis leaves 
 
  (Mohn et al., Planta Med 2008; 74:582-587).  
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Introduction

Woad (Isatis tinctoria L., family Brassicaceae) had
been used as an indigo dye in Central Europe
since antiquity and as a medicinal plant for the
treatment of inflammatory diseases [1]. In China,
Banlangen (Isatis root) and Daqingye (Isatis leaf)
from the taxonomically closely related Isatis
indigotica Fort. remain until now important herb-
al drugs in Traditional Chinese Medicine (TCM)
for the treatment of inflammatory ailments. We
investigated the anti-inflammatory potential of
I. tinctoria leaf extracts in a broad-based pharma-
cological screening, and tryptanthrin, γ-linolenic
acid and 1,3-dihydro-3-[(4-hydroxy-3,5-dime-
thoxyphenyl)methylene]-2H-indol-2-one were
identified as active principles inhibiting cyclooxy-
genase-2, 5-lipoxygenase, the expression of the in-
ducible nitric oxide synthase, human neutrophil
elastase, and the release of histamine from mast
cells [2], [3], [4], [5], [6]. Animal pharmacological
studies [7], [8] and a clinical pilot study [9] corro-
borated the potential of lipophilic Isatis extracts as
an anti-inflammatory.
Parallel to these pharmacological investigations,
phytochemical and analytical studies of the plant
were carried out. We previously reported season-
al variations of indigo precursors in woad leaves
and observed that the phytochemical profiles of
Isatis tinctoria L. (woad) and I. indigotica Fort. un-
derwent profound changes during post-harvest
treatment. Indigo precursors largely dissap-
peared whereas pharmacologically active com-
pounds such as tryptanthrin were formed during
Abstract

The seasonal fluctuation of glucosinolates in five
defined Isatis tinctoria and one Isatis indigotica
accessions (first year, rosette stage), grown on
field plots under identical conditions, was inves-
tigated. Analysis of the intact glucosinolates was
carried out with shock frozen, freeze dried leaf
samples using a recently developed and valida-
ted PLE (pressurized liquid extraction) protocol
and ion-pair HPLC coupled with ESI-MS in the
negative mode. When comparing the two Isatis
species, significant qualitative and quantitative
differences in the glucosinolate patterns were
observed. Differences among the various Isatis
tinctoria accessions weremuch smaller. We stud-
ied the effects of repeated harvesting during the
growth season on glucosinolate concentrations
and found that repeated harvest did not have a
major effect on glucosinolate concentrations of
newly grown leaves. Glucosinolates could not be
detected in woad leaves submitted to conven-
tional drying.
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the drying process [10], [11]. In fresh woad leaves, two classes of
secondary metabolites occur in rather high concentrations,
namely the indigo precursors, such as indican, and isatans A
and B [12], and glucosinolates [13], [14], [15], [16].
As part of a comprehensive metabolite profiling, we here report
on the seasonal fluctuation of glucosinolates in five I. tinctoria
accessions grown under identical conditions. For comparative
purposes, we also analyzed the glucosinolate pattern of the
closely related I. indigotica. The effects of repeated harvesting
during the growth season on glucosinolate concentrations, and
the influence of post-harvest processing were studied.
Materials and Methods

Chemicals and reference compounds
Analytical grade solvents for extraction and HPLC grade solvents
for chromatography were purchased from Scharlau. HPLC grade
water was obtained by an EASY-pure II (Barnstead) water purifi-
cation system. Ammonium formate (≥ 99.995%) and sinigrin (2)
(propenyl glucosinolate) (> 99%) were purchased from Sigma-
Aldrich.
Potassium salts of progoitrin (3) [2(R)-2-hydroxy-3-butenyl glu-
cosinolate], epiprogoitrin (1) [2(S)-2-hydroxy-3-butenyl glucosi-
nolate], gluconapin (4) (3-butenyl glucosinolate) and glucotro-
paeolin (7) (phenylmethyl glucosinolate) were purchased from
the Department of Natural Sciences, University of Copenhagen,
Denmark. Glucobrassicin (8) (3-indolmethyl glucosinolate), sul-
foglucobrassicin (5) (1-sulfo-3-indolylmethyl glucosinolate), 4-
hydroxyglucobrassicin (6) (4-hydroxy-3-indolylmethyl glucosi-
nolate) and neoglucobrassicin (9) (N-methoxy-3-indolylmethyl
glucosinolate) were isolated from seeds of I. tinctoria. Purity
and structures of isolated compounds were confirmed by NMR
and LC-MS experiments as previously described [17].
Plant material
Leaf material of five defined strains of I. tinctoria (“Thüringer
Waid”, “Jenaer Waid”, “Kieler Waid”, “French Woad” and “Swiss
Woad”) was harvested in 2003 on June 11 and 23, on July 16 and
29, on August 21, and on September 15, from one-year-old plants
(rosette stage). Furthermore, leaf material of I. indigotica Fort.
was collected on the same days as I. tinctoria. Plants were grown
under identical conditions on experimental plots of the Agricul-
tural Research Station of Thuringia (TLL), Dornburg, Germany, in
uniform rows without randomization. “Thüringer Waid is a mix
of genotypes growing in the state of Thuringia which has been
cultured for many years. The strains “Jenaer Waid”, “Kieler
Waid” and “Swiss woad” originated from plants grown at the
botanical gardens of the University of Jena, Germany, the Univer-
sity of Kiel, Germany, and the University of Lausanne, Switzer-
land, respectively. “French woad” is from a collection of wild
plants growing at Château de Magrin, near Toulouse, France. I.
indigotica was from the botanical garden of the University of
Bristol, England. The strains were obtained in 1991/1992 by se-
lection breeding of plants with positive traits grown and multi-
plied under isolation conditions. Annual elimination of plants
which did not correspond to the desired phenotype led to a
high degree of phenotypical homogeneity of the strains by the
year 2003. Specimens of seeds from the strains are kept at the
TLL, under accession numbers 153/PG 1 (Thüringer Waid), 153/
PG 4 (Swiss woad, 153 PG 5 (French woad), 153 PG 9 (Kieler
Waid), 153 PG 10 (Jenaer Waid) and 153 PG 12 (Isatis
indigotica). Sowing was in early spring at 5 kg seeds/ha, nitrogen
fertilization was at 120 kg N/ha at the time of sowing, and 50 kg
N/ha each after first and second cuts. A defined treatment of her-
bicides was applied for weed control. In addition to plants that
were left to grow over the entire growth period without being
cut, further plants from the strains “JenaerWaid” and “Thüringer
Waid” were cultivated under identical conditions but leaf ro-
settes were cut with a mowing machine on June 24 and July 31,
and the newly grown leaves were analyzed to study the effects of
repeated harvesting. Samples were taken on the same harvest
dates as described above, with the exception of June 11.
Sample preparation and extraction
Freshly harvested Isatis leaf material was cut into small pieces of
2–3 cm length and immediately shock frozen with liquid nitro-
gen. Prior to extraction, the leaves were lyophilized for 48 h
(Freezemobile 12XL, Virtis), powdered frozen in liquid nitrogen
with a ZM 1 ultracentrifugal mill (Retsch, with 0.75mm Conidur
sieve) and kept frozen at below –20 °C until extraction. In addi-
tion, entire leaves were dried at room temperature or at 40 °C in
a thermostatted oven as described previously [11] to investigate
the influence of different post-harvest treatments. Pressurized
liquid extraction (PLE) of 1.0 g frozen and powdered samples
was carried outwith anASE 200 instrument (Dionex)with attach-
ed solvent controller. Conditions for all extractions were as fol-
lows: extraction solvent: 70% methanol in water; temperature:
50 °C; 3 extraction cycles of 5min; preheat time: 1min; flush:
100% of cell volume; purge: 80 s with nitrogen; pressure:
120bar; 11mL steel cartridges. The extracts of 3 extraction cycles
were combined, and the solvent was evaporated under reduced
pressure. Dried extracts were stored at below -20 °C until analysis.
LC-MS instrumentation and conditions
HPLC separations were carried out on an Agilent series 1100 sys-
tem equippedwith degasser, binary high pressuremixing pump,
column thermostat and photodiode array (PDA) detector (Agi-
lent Technologies). A liquid handler 215 (Gilson) was used as au-
tosampler. The HPLC was coupled to an Esquire 3000 plus ion
trap mass spectrometer equipped with an electrospray (ESI) in-
terface (Bruker Daltonics). Data acquisition and processing was
performed using HyStar 3.0 software (Bruker Daltonics).
Separations were carried out on an Aqua C18 125 Å column
(5 μm, 250×4.5mm I.D.; Phenomenex) equipped with a guard
column (4.0×3.0mm I.D.). Mobile Phase A consisted of a solu-
tion of 10mM aqueous ammonium formate, adjusted to pH 6.4.
Mobile phase B was acetonitrile. A linear gradient starting at 1%
B to 3% B (7min), 3% B to 15% B (5min), 15% B to 30% B (13min)
was used to separate all compounds of interest. Flow rate was
1.0mL/min. A split ratio of 1:4 was used with the ESI interface.
Column temperature was 20.0 °C. The sample injection volume
was 20 μL.
Negative ion LC-MS on the ion trap instrument were recorded af-
ter optimization of settings, under ion charge conditions (ICC
30000) at a scan speed of 13000m/z/s, using a Gauss filter width
of 0.2 m/z. Nitrogen was used as a drying gas at a flow rate of 10
L/min and as a nebulizing gas at a pressure of 30 psi. The nebu-
lizer temperature was set at 300 °C. Spectra were recorded be-
tween 0min and 25min in the range ofm/z 100 to 800. Capillary
voltage was at 4500 V, endplate offset at –500 V, capillary end
voltage at –115.0 V, skimmer voltage –40.0 V and trap drive at
53.4. Details on method development and validation procedures
for the PLE/LC-MS protocol have been reported [17].
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Quantitative analysis
A solution of 10mM ammonium formate containing sinigrin
(2mg/L) as internal standard (IS solution) was used for all dilu-
tion steps. Stock solutions (1mg/mL) of all reference compounds
were prepared in IS solution, serial dilutions covered a concen-
tration range of 20 to 0.1 μg/mL. Each standard solution was
measured in triplicate.
The dried extracts, obtained by extraction of 1.0 g frozen, pow-
dered leaf material, were dissolved in 100.0mL IS solution. Fur-
thermore, a dilution of 1:100 was prepared with IS solution. All
solutions were centrifuged (5min, 1600×g, 4 °C) prior to LC-MS
analysis. Measurements were made in triplicate.
Supporting information
Figures representing seasonal changes for individual glucosino-
lates of Isatis tinctoria accessions, and Isatis indigotica are avail-
able as Supporting Information.
Results and Discussion

Analysis of glucosinolates 1–9 (● Fig. 1) was carried out with a
recently developed and validated PLE protocol and ion-pair
HPLC coupled with ESI-MS detection in negative mode [17]. Cal-
ibration curves were found to be quadratic functions over a con-
centration range of 0.1 to 20 μg/mL. Regression coefficients
ranged between 0.9995 and 1. ● Fig. 2 shows the extracted ion
chromatogram (EIC) of the reference compounds 1–9, the base
peak chromatogram (BPC) of the extracts, and the EIC used for
peak integration of the identified glucosinolates.
Leaf extracts of I. tinctoria and I. indigotica showed significant
qualitative and quantitative differences in their glucosinolate
pattern (● Fig. 2). Glucobrassicin (5) and sulfoglucobrassicin
(8), the major glucosinolates of I. tinctoria, could not be identi-
fied in the taxiconomically closely related species I. indigotica.
Progoitrin (3) and 4-hydroxyglucobrassicin (6) constituted the
main glucosinolates in I. indigotica. The aliphatic glucosino-
lates epiprogoitrin (1) and epiprogoitrin (3) were present in
higher concentrations than in leaves of I. tinctoria (Supporting
Information Fig. 8S). The total glucosinolate content in I.
indigotica (28.6 μmol/g dry weight) was only about 50% of the
average total glucosinolate content in I. tinctoria (accession “Je-
naer Waid”) (50.5 μmol/g dry weight). Until recently, I.
indigoticawas considered to be a subspecies of I. tinctoria , but
amplified fragment length polymorphism (AFLP) analysis
showed that they have to be considered as two different spe-
cies [18]. The differences in glucosinolate pattern corroborate
these findings.
The analysis of leaves from different I. tinctoria accessions
showed that the glucosinolate pattern was subject to seasonal
changes. The aliphatic glucosinolates examined here were glu-
conapin (4), progoitrin (3), and its epimer epiprogoitrin (1). Al-
though these compounds constitute minor glucosinolates in
Isatis leaves (0.1–1.3 μmol/g for 1 and 3, and 0.01–0.04 μmol/g
for 4) compared to the indole glucosinolates, changes within
the growth period were observed. Samples collected on six dif-
ferent dates showed that four out of five accessions reached
highest concentrations of aliphatic glucosinolates towards end
of June, whereas peak concentrations were earlier in the case of
“French woad” (● Fig. 3). A steady decline was observed in the
later dates of sampling. Sampling before the June 11 date was
not possible, since the plantlets were too small. June represents
the earlier part of the vegetation period for woad in its first year
culture (rosette stage). Similar decrease of aliphatic glucosino-
late concentration during the vegetative stage has been ob-
served for other cruciferous species, such as rape (Brassica
napus) [19], [20].
Glucobrassicin (8), and its derivatives sulfoglucobrassicin (5), 4-
hydroxyglucobrassicin (6) and neoglucobrassicin (9) are indolic
glucosinolates in I. tinctoria. The concentrations of the major
compounds 5 and 8 were approx. 100-fold higher than those of
aliphatic glucosinolates epiprogoitrin (1) and progoitrin (3). For
the five accessions in our study, the concentrations of total indole
glucosinolates were lowest in the young plantlets, and increased
several fold to reach amaximum in July/August (● Fig. 4). A closer
analysis of data revealed that the increase was due to sulfogluco-
brassicin (5), whereas the concentration of glucobrassicin (8) re-
mained fairly constant throughout the vegetation season. This
trend is illustrated here with the example of the accession “Thür-
inger Waid” (● Fig. 5). The other indole glucosinolates in leaves,
4-hydroxyglucobrassicin (6) and neoglucobrassicin (9) occurred
in approx. 100-fold lower concentrations (Supporting Informa-
tion, Figs. 4S and 7S), and did not showa consistent pattern of sea-
sonal change. Neither glucotropaeolin (7), a simple aromatic glu-
Fig. 1 Structures of glucosinolates 1–9.
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cosinolate, nor further indolic glucosinolates reported from I.
tinctoria seeds [16] were detected in any of the leaf samples.
The comparison of five different I. tinctoria accessions revealed
some differences in their glucosinolate patterns. Leaf samples
of the strain “Kieler Waid” had the lowest total glucosinolate
concentration. The highest concentration of the major com-
pound sulfoglucobrassicin (5) was found in “Thüringer Waid”
which, on the other hand, exhibited the least diverse spectrum
in other glucosinolates. Gluconapin (4) and neoglucobrassicin
(9) were not detectable in “Jenaer Waid and “Thüringer Waid”,
and the latter also did not contain 4-hydroxyglucobrassicin (6)
(Supporting Information, Figs. 1S–7S). The differences in gluco-
sinolate pattern seem to reflect the relatively high degree of ge-
netic diversity and varying phenotypic characteristics that were
recently reported for European I. tinctoria landraces [18].
The effect of repeated harvesting on the qualitative and quanti-
tative composition in glucosinolates was studied with the acces-
sions “JenaerWaid” and “ThüringerWaid”. On one half of the ex-
perimental plots plants were left untouched, and only small leaf
samples were taken for analysis. On the other part of the plot,
the fully grown leaf rosettes were cut with a mowing machine
on June 24 and July 31, in order to simulate subsequent harvests
during the vegetation season. From the regrown leaf rosettes of
these plants, small leaf samples were then taken for analysis at
the indicated dates (● Fig. 6). A comparison of glucosinolate
concentrations in these leaf samples revealed no substantial dif-
ferences between the untouched plants and those with a newly
regrown leaf rosette. As shown for sulfoglucobrassicin (5)
(● Fig. 6), repeated harvest did not have a major effect on the
glucosinolate concentration of newly grown leaves. Data for epi-
progoitrin (1), progoitrin (3) and glucobrassicin (8) are given as
Supporting Information, Figs. 9S–11S.
This study is the first to address seasonal changes of glucosino-
lates in Isatis sp., and in particular in I. tinctoria. Sulfoglucobras-
sicin (5), the main indole glucosinolate, accumulated in the
leaves over most of the vegetation period. Biosynthetic studies
on indolic glucosinolates suggest that glucobrassicin (8) is con-
Fig. 2 HPLC separation of a mixture of reference compounds 1–9 (top).
Sinigrin (IS) is used as internal standard. Base peak chromatograms (BPC)
and Extracted ion chromatograms (EIC) of the major glucosinolates are
shown below for leaf extracts of Isatis tinctoria “Jenaer Waid” and Isatis in-
digotica.
Fig. 4 Concentration of total indolic glucosinolates sulfoglucobrassicin
(5), 4-hydroxyglucobrassicin (6), glucobrassicin (8), and neoglucobrassicin
(9) in shock frozen, freeze-dried leaves of Isatis tinctoria accessions “Swiss
woad” (SW), “Kieler Waid” (KW), “Jenaer Waid” (JW), “Thüringer Waid”
(TW) and “French woad” (FW). The data points represent the sum calcu-
lated for dried plant material at the respective dates of sampling. Data for
individual glucosinolates are given as Supporting Information.
Fig. 3 Concentration of total aliphatic glucosinolates epiprogoitrin (1),
progoitrin (3) and gluconapin (4) in shock frozen, freeze-dried leaves of
Isatis tinctoria accessions “Swiss woad” (SW), “Kieler Waid” (KW), “Jenaer
Waid” (JW), “Thüringer Waid” (TW) and “French woad” (FW). The data-
points represent the sum calculated for dried plant material at the respec-
tive dates of sampling. Data for individual glucosinolates are given as
Supporting Information.
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verted to sulfoglucobrassicin (5), neoglucobrassicin (9) and 4-
hydroxyglucobrassicin (5) before the initiation of a de novo bio-
synthesis of glucobrassicin (8) [21].
Glucosinolates are considered as typical defense compounds of
Brassicaceae [22], and their synthesis can be induced to a certain
extent by stress. We, therefore, initially thought that glucosino-
late concentrations in the regrown leave rosette of the mowed
plants would be possibly higher than in the control plants. In-
crease of indole glucosinolates after puncturing leaves with nee-
dles had been reported with rape and mustard cotyledons [23].
However, this upregulation of biosynthesis was only a transient
phenomenonwith a maximum one day after wounding, and two
weeks later the concentration had dropped to the level of un-
treated control plants. Considering the mowing and sampling
regime in our study, the observed lack of marked changes in glu-
cosinolate pattern is in line with these findings. Multiple har-
vesting of leaf rosette would increase the overall yield of plant
material without significantly modifying the phytochemical
composition of the leaves, at least for glucosinolates.
As for indigo precursors [10] and tryptanthrin [11], we investiga-
ted the influence of the drying procedure on glucosinolate con-
tent. In contrast to the shock frozen freeze dried leaf samples,
none of the glucosinolates including the major compounds sul-
foglucobrassicin (5) and glucobrassicin (8), could be detected in
plant material that had been dried at ambient temperature or at
40 °C (data not shown). However, wewere not able to detect any
of the known breakdown products of indolic glucosinolates such
as indole-3-carbinols [(1H-indol-3-yl)methanol and deriva-
tives], indole-3-acetonitriles [2-(1H-indol-3-yl)acetonitrile and
derivatives] and its corresponding isothiocyanates as well as di-
meric compounds as 3,3′-diindolylmethanes [bis(1H-indol-3-
yl)methane and derivatives] or indolyl ascorbigens (indol-3-
ylascorbigen and derivatives) described in earlier studies [24],
[25], [26], [27]. The degradation products of indol glucosinolates
in woad are presently unknown, and it remains to be clarified
whether they contribute in any form to the post-harvest forma-
tion of indol-derived compounds such as tryptanthrin.
We previously analyzed the indigo precursors isatan A, isatan B
and indican in the same Isatis samples [10]. The concentration of
total indigo precursors was approximately in the same range as
that of the indole glucosinolates (3–5% of dry weight). Hence,
tryptophan-derived secondary metabolites clearly dominate in
woad. However, the concentration of indole glucosinolates was
higher in I. tinctoria than in I. indigotica, whereas the indigo pre-
cursors were higher in I. indigotica. This suggests that the bio-
synthesis of these compounds may be limited by the supply in
the precursor amino acid, and secondary metabolism of I.
tinctoriamay tend more towards indole glucosinolate synthesis,
and I. indigotica towards production of indigo precursors.
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Fig. 1S Concentration of epiprogoitrin (1), in shock frozen, freeze-dried leaves of 
Isatis tinctoria accessions. The dates of sampling are indicated in the graph.  
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Fig. 2S Concentration of progoitrin (3), in shock frozen, freeze-dried leaves of Isatis 
tinctoria accessions. The dates of sampling are indicated in the graph.  
 
© Georg Thieme Verlag KG · DOI 10.1055/s-2008-1074504 · Planta Med · Mohn T et al.
139
30.00
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
11-06-03 23-06-03 16-07-03 29-07-03 21-08-03 15-09-03
G
lu
co
si
no
la
te
co
nt
en
t[
µm
ol
/g
]
Harvesting date
Gluconapin
Kieler Waid
Swiss woad
French woad
 
Fig. 3S Concentration of gluconapin (4), in shock frozen, freeze-dried leaves of Isatis 
tinctoria accessions. The dates of sampling are indicated in the graph. The 
compound was below detection limit in the accessions “Jenaer Waid” and “Thüringer 
Waid”. 
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Fig. 4S Concentration of 4-hydroxyglucobrassicin (6), in shock frozen, freeze-dried 
leaves of Isatis tinctoria accessions. The dates of sampling are indicated in the 
graph. The compound was below detection limit in the accession “Thüringer Waid”. 
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Fig. 5S Concentration of sulfoglucobrassicin (5), in shock frozen, freeze-dried leaves 
of Isatis tinctoria accessions. The dates of sampling are indicated in the graph.  
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Fig. 6S Concentration of glucobrassicin (8), in shock frozen, freeze-dried leaves of 
Isatis tinctoria accessions. The dates of sampling are indicated in the graph.  
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Fig. 7S Concentration of neoglucobrassicin (9), in shock frozen, freeze-dried leaves 
of Isatis tinctoria accessions. The dates of sampling are indicated in the graph. The 
compound was below detection limit in the accessions “Jenaer Waid” and “Thüringer 
Waid”. 
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Fig. 8S Concentration of epiprogoitrin (1), progoitrin (3), gluconapin (4) and 4-
hydroxyglucobrassicin (6) in shock frozen, freeze-dried leaves of Isatis indigotica. 
The dates of sampling are indicated in the graph.  
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Fig. 9S Concentration (µmol/g) of epiprogoitrin (1) in leaf samples of Isatis tinctoria 
accessions “Jenaer Waid” (JW) and “Thüringer Waid” (TW) at the indicated harvest 
dates, compared to epiprogoitrin concentration in leaf material from plants which 
were subjected to periodical mowing (JW cut) and (TW cut).  
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Fig. 10S Concentration (µmol/g) of progoitrin (3) in leaf samples of Isatis tinctoria 
accessions “Jenaer Waid” (JW) and “Thüringer Waid” (TW) at the indicated harvest 
dates, compared to progoitrin concentration in leaf material from plants which were 
subjected to periodical mowing (JW cut) and (TW cut).  
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Fig. 11S Concentration (µmol/g) of glucobrassicin (8) in leaf samples of Isatis 
tinctoria accessions “Jenaer Waid” (JW) and “Thüringer Waid” (TW) at the indicated 
harvest dates, compared to glucobrassicin concentration in leaf material from plants 
which were subjected to periodical mowing (JW cut) and (TW cut).  
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Glucosinolate Pattern in Isatis
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Abstract

The glucosinolate patterns in seeds of five Isatis tinctoria and
two Isatis indigotica accessions were assessed with a recently
developed and validated LC-MS assay for direct analysis of glu-
cosinolates without prior desulfatation. Glucosinolate peaks
were identified with in-source fragmentation and detection of
the sulfate anion (m/z = 97), and by MS/MS experiments. The
glucosinolate patterns of the seeds showed characteristic differ-
ences compared to leaves. Glucoisatisin and epiglucoisatisin
were diagnostic of seed samples. Qualitative and quantitative
differences in glucosinolate patterns between both Isatis species
were found for seed samples, enabling a differentiation of the
two medicinal plants at the level of seed material.
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Isatis tinctoria L. and I. indigotica Fort. (Brassicaceae) are ancient
indigo dyes and medicinal plants in Europe and in Traditional
Chinese Medicine (TCM), respectively [1]. In recent years, the
two species were intensively investigated from a phytochemical
and pharmacological viewpoint [2], [3], [4], [5], [6], [7], and in a
clinical pilot study [8]. Seasonal variation of the twomost abun-
dant classes of secondarymetabolites in Isatis leaves, indigo pre-
cursors and glucosinolates, and changes in metabolite profiles
during post-harvest treatment have been studied [9], [10], [11].
Characteristic differences in glucosinolate pattern were ob-
served in leaves of I. tinctoria and I. indigotica, corroborating the
recent separation into two distinct species [12].
Comparatively little is known about the glucosinolates in seeds
[13], [14], [15]. We here report on the identification of further in-
dole glucosinolates in seeds of five different I. tinctoria and two
I. indigotica accessions. First, analysis of glucosinolates (structures
see ● Fig. 1) was undertaken with a recently developed and va-
lidated pressurized liquid extraction (PLE) protocol and ion-pair
HPLC coupledwith ESI-MS detection in negative ionmode under
full scan conditions [16]. In a second HPLC run, peaks corre-
sponding to glucosinolates were earmarked via in-source frag-
mentation and detection of the fragment ion m/z = 97 ([SO4H]–).
In addition, MS/MS experiments were carried out to observe the
elimination of the sulfate anion. ● Fig. 2 shows the base peak
and extracted ion chromatograms of compounds 1–6, 8/8a and
9 in I. tinctoria seeds, the ion trace of them/z = 97 fragment, and
ESI-MS recorded under non-fragmenting conditions. LC-TOF-MS
in negative mode was used to determine the accurate molecular
mass of compounds (conditions see Mohn et al. [16]). Methods
for the identification of glucosinolates by MS/MS [17] and quan-
tification by multiple reaction monitoring (MRM) have been re-
cently described [18], [19], [20]. For a rapid search for glucosino-
lates, we found in-source fragmentation and detection of the
characteristicm/z = 97 [SO4H]– fragment ion to bemore sensitive
and easy to perform than MS/MS fragmentation. Absolute peak
intensities were 10 to 33 times higher for individual glucosino-
lates caused by in-source fragmentation while MS/MS fragmen-
tation gave equal or lower relative peak intensities for the m/z =
97 [SO4H]– fragment ion (● Table 1). These findings are in agree-
ment with observations of Mellon et al. [18].
Characteristic differences in the glucosinolate patterns between
leaves and seeds were found. Sulfoglucobrassicin (10), the major
glucosinolate in I. tinctoria leaves, was absent in the seed ex-
tracts of either species. Glucoisatisin and epiglucoisatisin (8/8a;
calcd. 562.0927; found 562.0930 and 562.0932) were found in
Fig. 1 Structures of
compounds 1–10.
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the seeds of both Isatis species. These two compounds have been
recently identified as an unseparable epimeric mixture from I.
tinctoria seeds [14]. The two compounds were not found in
leaves of the two species [11] and thus can be considered as
markers of seed material. Two other glucosinolates reported by
Frechard et al. [14], 3′-hydroxyglucoisatisin and 3′-hydroxyepi-
glucoisatisin, could not be detected in any of the Isatis seed sam-
ples. A further indolic glucosinolate, 4-methoxyglucobrassicin
(7; calcd. 478.0716, found: 478.0713), was detected as a trace
compound in both I. indigotica seed samples, but was absent
from any of the I. tinctoria accessions.
A recent comparison of glucosinolate patterns in leaves revealed
significant qualitative and quantitative differences between the
two Isatis sp., but comparativey small differences between the I.
tinctoria accessions [11]. A similar observation could be made in
case of the seeds. Comparison of HPLC profiles (● Fig. 3, and
Fig. 1S in Supporting Information) showed that glucobrassicin
(6) and neoglucobrassicin (9) were only present in I. tinctoria
seeds, whereas 4-methoxyglucobrassicin (7) was only found in
I. indigotica.
Only one study (Elliott and Stowe [13]) has been carried out to
investigate the distribution of glucosinolates in seeds and leaves
of I. tinctoria. They found glucobrassicin (6) to be the only gluco-
sinolate in the seeds while glucobrassicin (6), neoglucobrassicin
(9) and sulfoglucobrassicin (10) were identified in the leaves in
considerable amounts. Our results support these findings, with
the exception of neoglucobrassicin (9) which was present in all
strains of Isatis tinctoria seeds. However, Elliott and Stowe did
not analyze other indolic glucosinolates in their study and did
not investigate differences between the Isatis species. The con-
tent of total glucosinolates in seeds of both species was lower
than in the corresponding leaf samples (● Table 2, and Table 1S
in Supporting Information). Isatis tincoria seeds containedmain-
ly aliphatic glucosinolates, whereas indolic glucosinolates were
Fig. 2 Glucosinolates in Isatis seed extracts. Base peak chromatogram
(BPC; A) and extracted ion chromatogram (EIC; B) of major glucosino-
lates are shown for Isatis tinctoria accession “Thüringer Waid”. Sinigrin
(2) was used as internal standard (IS). The trace of ion 97 m/z ([SO4H]–)
resulting from in-source fragmentation was used to selectively detect all
glucosinolate peaks (C). Mass spectra of compounds 1–9 recorded un-
der non-fragmenting conditions are shown below (C).
Table 1 Comparison of fragmentation conditions. In-source fragmentation gave equal or higher relative signal intensities compared to fragmentation by MS/
MS, and the absolute signal intensity was clearly higher for the sulfate fragment m/z = 97 via in-source fragmentation
Compound Relative signal intensity of the m/z = 97 [SO4H]–fragment ion Absolute signal intensity ratio in-source
vs. MS/MS fragmentation
In-source fragmentation Fragmentation by MS/MS
Epiprogoitrin (1) 100% 100% 16:1
Progoitrin (3) 100% 100% 12:1
Gluconapin (4) 100% 100% 33:1
4-Hydroxyglucobrassicin (5) 51% 24% 10:1
Glucobrassicin (6) 79% 62% 16:1
Glucoisatisin/Epiglucoisatisin (8/8a) 100% 16% 20:1
Neoglucobrassicin (9) 100% 15% 10:1
Fig. 3 Comparison of glucosinolates in Isatis seed extracts. Extracted
ion chromatograms (EIC) of glucosinolates in Isatis indigotica (Shanghai)
and of the Isatis tinctoria accession “Thüringer Waid” (TW). Sinigrin (2)
was used as internal standard (IS).
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dominant in the leaves [11]. In summary, our findings show or-
gan-specific differences in glucosinolates. In combination with
our previously reported results [11] these findings support the
molecular taxonomy [12] showing that Isatis tinctoria and Isatis
indigotica should be considered as separate species. From a prac-
tical viewpoint, seed material of Isatis species can be easily dif-
ferentiated on the basis of characteristic glucosinolate pattern.
Materials and Methods

Seeds of defined strains of Isatis tinctoria (“ThüringerWaid”, “Je-
naer Waid”, “Kieler Waid”, “French Woad” and “Swiss Woad”)
were obtained from the Agricultural Research Station of Thurin-
gia (TLL), Dornburg, Germany. Isatis indigotica seeds were pur-
chased from Sand Mountain Herbs (“Isatis indigotica USA”) and
from the Shanghai Institute of Materia Medica, Shanghai, China
(“Isatis indigotica Shanghai”). Voucher specimens are kept at the
Institute of Pharmaceutical Biology, University of Basel under ac-
cession numbers 153 PG 1 (Thüringer Waid), 153 PG 4 (Swiss
woad), 153 PG 5 (French woad), 153 PG 9 (Kieler Waid), 153 PG
10 (Jenaer Waid), 153 PG 20 (Isatis indigotica USA) and 163 PG
21 (Isatis indigotica Shanghai).
Glucosinolate analysis was carried out according to a published
protocol [16] with small modifications in the HPLC gradient. The
mobile phase consisted of an aqueous solution of 10mM ammo-
nium formate (adjusted to pH 6.4 with formic acid; eluent A)
and acetonitrile (eluent B). The gradient of B was as follows:
from 1% to 3% in 7min, 3% to 15% (5min), 15% to 17% (3min),
held at 17% for 2min, 17% to 19% (4min), held at 19% for 3min,
19% to 24% (6min). Flow rate was 1.0mL/min. A split ratio of
1 :4 was used with the ESI interface. Separations were carried
out on an Aqua C18 125 Å column (5 μm, 250×4.5mm I.D.; Phe-
nomenex) equipped with a guard column (4.0×3.0mm I.D.) at
20.0 °C. The sample injection volume was 20 μL. LC-TOF-MS in
negative mode was used to confirm the molecular formula of
glucosinolates (see [16]).
For the detection of the fragment ion m/z = 97 ([SO4H]–) mass
spectrometric conditions of the Esquire 3000 plus ion trap MS
were optimized as follows: ion charge control: (ICC 30000),
scan speed: 13000m/z/s, gauss filter width: 0.2m/z, nitrogen as
drying gas (10 L/min) and nebulizing gas (30 psi), nebulizer tem-
perature: 300°C, capillary voltage: 4107 V, endplate offset: –500
V, skimmer voltage: –87.5 V and trap drive: 28.4. Spectra were
recorded in the range of 70 to 650m/z.
MSn experiments were performed on the glucosinolate [M - H]–
ions using helium as collision gas. The isolation width was set
to 4.0 m/z and the fragmentation amplitude was set to 1.00 V in
the `smart fragmentation' mode. ESI source voltages were as fol-
lows: capillary voltage at 4500 V, endplate offset at –500 V, ca-
pillary exit offset at –115 V, skimmer voltage at –40.0 V and trap
drive at 53.4. The scan range for mass spectra was 80m/z to 800
m/z.
Supporting information
EIC spectra of glucosinolates from Isatis seeds and concentration
of glucosinolates in Isatis seeds in comparison to published data
of Isatis leaf material and seeds are available as Supporting Infor-
mation.
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Figure 1. Glucosinolates in Isatis seeds. Extracted ion chromatograms (EIC) of 
identified glucosinolates of the Isatis tinctoria accessions “Thüringer Waid” (TW), 
“French Woad” (FW), “Swiss Woad” (SW), “Kieler Waid” (KW), “Jenaer Waid” (JW)  
and of “Isatis indigotica “Shanghai”  and “Isatis indigotica USA” are shown. Sinigrin 
(2) was used as internal standard (IS). 
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Table 1. Concentration of glucosinolates in Isatis seeds in comparison to published data of Isatis leaf material and seeds 
 
Leaves           
           
Data from Mohn et al. [16] (amount of glucosinolates calculated in mg / 100 g dry weight)      
Isatis tinctoria ("Thüringer Waid")   Isatis indigotica       
  amount in  
mg / 100 g dw 
   amount in  
mg / 100 g dw 
    
      Data from Elliott and Stowe [13]  
glucosinolate mina maxa  glucosinolate mina maxa  Isatis tinctoria   
Epiprogoitrin (1) 0.574 21.8  Epiprogoitrin (1) 11.9 45.3    amount in mg /100 g dw 
Progoitrin (3) 0.374 28.3  Progoitrin (3) 194.5 546.6    Light 
grown 
shoots 
Etiolated 
shoots Gluconapin (4) n.d. 0.5  Gluconapin (4) 0.3 16.7  glucosinolate 
Sulfoglucobrassicin (10) 553.9 4482.6  Sulfoglucobrassicin (10) n.d. n.d.  Sulfoglucobrassicin (10) 50.2 11 
4-Hydroxyglucobrassicin (5) n.d. n.d.  4-Hydroxyglucobrassicin (5) 213.8 1762.7  4-Hydroxyglucobrassicin (5) n.d.  n.d. 
Glucobrassicin (6) 157.3 401.7  Glucobrassicin (6) n.d. n.d.  Glucobrassicin (6) 175.6 160 
4-Methoxyglucobrassicin (7) n.d. n.d.  4-Methoxyglucobrassicin (7) n.d. n.d.  Neoglucobrassicin (9) 3.4 132 
Glucoisatisin (8/8a) n.d. n.d.  Glucoisatisin (8/8a) n.d. n.d.   
Neoglucobrassicin (9) n.d. 2.7  Neoglucobrassicin (9) n.d. n.d.     
           
Seeds           
           
Isatis tinctoria ("Thüringer Waid")   Isatis indigotica (Shanghai)   Data from Elliott and Stowe [13]  
  amountb 
in mg / 
100 g 
dw 
    amountb 
in mg / 
100 g 
dw 
  Isatis tinctoria   
glucosinolate   glucosinolate   glucosinolate 
amount in 
mg /100 g 
dw  
Epiprogoitrin (1) 130   Epiprogoitrin (1) 50   Sulfoglucobrassicin (10) n.d.  
Progoitrin (3) 90   Progoitrin (3) 140   4-Hydroxyglucobrassicin (5) n.d.  
Gluconapin (4) 55   Gluconapin (4) 10   Glucobrassicin (6) 230  
Sulfoglucobrassicin (10) n.d.   Sulfoglucobrassicin (10) n.d.   Neoglucobrassicin (9) n.d.  
4-Hydroxyglucobrassicin (5) 15   4-Hydroxyglucobrassicin (5) 10    
Glucobrassicin (6) 45   Glucobrassicin (6) n.d.     
4-Methoxyglucobrassicin (7) n.d.   4-Methoxyglucobrassicin (7) traces      
Glucoisatisin (8/8a) 90   Glucoisatisin (8/8a) 120   
 
 
(both isomers together)     (both isomers together)       
Neoglucobrassicin (9) 10   Neoglucobrassicin (9) n.d.      
n.d. = not detected           
a amount glucosinolates depending on seasonal variation       
b values estimated 
           
  
 
 
4. CONCLUSION AND OUTLOOK 
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The future aim is to establish a new phytomedicinal product based on a lipophilic woad 
extract as a “New Herbal Entity” (NHE = herbal remedy without traditional use). As for 
the vast majority of phytomedicines, the known active compounds in woad amount only 
to a small proportion of the total extract, while the composition of the extract matrix 
remains unclear. A systematic investigation of the metabolite profile of Isatis tinctoria 
leaf extracts was therefore carried out using a combination of HPLC-based MS and 
NMR profiling techniques. Approximately 90% of the pharmacologically active 
dichloromethane extract could be assigned to particular compounds or compound 
classes (by taking the relative peak areas of the ELSD profile as a measure). This is 
comparable or better than the state of knowledge for well-characterised special extracts, 
such as EGb 761 from Gingko biloba L. and ZE 331 from Petasites hybridus L. which 
are active ingredients in well-known phytopharmaceuticals. The applied analytical 
methods enable a profiling of Isatis extracts in a holistic manner and will provide a 
means of standardisation and quality control of Isatis based on its entire composition. 
To our knowledge, this was the first time in natural product analysis that such a broad 
range of detectors/detection modes were used in parallel. It enabled the detection of a 
structurally highly diverse spectrum of metabolites.  Our approach is of general interest 
for any profiling/metabolomics study.  
The sourcing of homogenous raw material represents another challenge in the 
development of a new phytomedicine. Our investigations on five different I. tinctoria 
strains revealed some differences in the secondary metabolite patterns due to a relative 
high degree of genetic diversity. With the used profiling strategies, it will be possible to 
select the best suitable Isatis variety and to standardise the plant cultivation process in 
order to develop an active herbal preparation that can be produced in an industrial 
scale.  
It is still unclear which precursor molecules are involved in the formation of tryptanthrin 
during harvest and post-harvest treatment. Clear evidences for a contribution of indole 
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glucosinolates are still missing so far. Isotope labelling of the indole unit of putative 
precursors, and the subsequent identification of the labelled indole units in tryptanthrin 
by NMR would provide direct evidence. However, this approach would be costly and 
time-consuming. Continuing experiments for the search of other possible candidates as 
precursor molecules should also be carried out. Whether previously identified 
precursors of indigo like isatan A and B are involved in the formation of tryptanthrin and 
other indole alkaloids in woad should be investigated. Knowledge on the formation of 
tryptanthrin would facilitate the optimisation of cultivation and post-harvest conditions. 
Besides the cultivation aspects, more investigations are needed to develop a woad 
based phytomedicine. The mode of action of the active principles is known only in part. 
Previous studies showed that tryptanthrin inhibits cycloxygenase-2 (COX-2) and 
lipoxygenase-5 (5-LOX) but the binding sites are still unknown. Studies analysing the 
interaction between the involved enzymes and tryptanthrin (e.g. analysed by SPR) 
would be suitable to reveal the binding sites. Further experiments are also needed to 
understand the mode of action of (E)-3-(3',5'-dimethoxy-4'-hydroxy-benzylidene)-2-
indolinone on a molecular level.  
Moreover, pharmacological synergies, through compounds acting on different targets 
involved in inflammation, seem to occur in woad. However, experimental evidence is 
lacking and needs to be provided for Isatis. Such findings would be of interest for 
phytomedicines in general. 
Finally, the bioavailability of active substances in a standardised woad extract has to be 
investigated, and toxicological studies in animals need to be carried out before legal 
authorities would allow first clinical efficacy studies.  
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